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As many as 82% of children with Autism Spectrum Disorders (ASD) experience
numerous chronic sleep-related problems and at a much higher frequency and severity
than their typically developing peers. Behavioral treatments are considered best practice
and first-line treatment to address sleep problems. These treatments tend to address one
specific sleep-related behavior at a time. Bedtime Fading with Response Cost (BFRC) is
a promising intervention that targets a multitude of sleep problems concurrently and has
yet to be replicated by more than one investigative team in the home setting with children
on the autism spectrum. This study evaluated the effectiveness of BFRC in decreasing
sleep disturbances in children with ASD using parents as change agents by implementing
treatment in the home environment. A non-concurrent multiple baseline design across
three participants was used. Results indicate that BFRC was effective in eliminating
unwanted co-sleeping, frequent night awakenings, and dependent sleep onset and
reducing sleep onset latency, bedtime resistance, and disruptive sleep-related behaviors.
Follow-up data demonstrate that gains were maintained. Parents reported high
satisfaction with BFRC and sleep outcomes for their children. This study extends both the
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practice and science of parent-implemented behavioral interventions as treatment options
for children with ASD and co-occurring sleep problems.
Keywords: autism, sleep, children, parents, behavioral intervention
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Bedtime Fading with Response Cost for Treatment of Sleep Disturbances in Children
with Autism Spectrum Disorder
Introduction
Background
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder affecting one
out of 68 children in the United States (Center for Disease Control and Prevention
[CDC], 2016). ASD is characterized by core deficits in social communication and social
interactions and atypical repetitive behaviors and restricted interests (American
Psychiatric Association [APA], 2013; CDC, 2016; Reynolds & Malow, 2011). Sleep
disturbance is one of the most common and challenging behaviors experienced by
children with ASD (Dominick, Ornstein Davis, Lainhart, Tager-Flusberg, & Folstein,
2007; Levin & Scher, 2016; Reynolds & Malow, 2011; Wiggs & Stores, 2004) and is
frequently associated with co-occurring behavioral difficulties (Adams, Matson, & Jang,
2014; Mazurek & Sohl, 2016). Prevalence rates of chronic sleep-related problems in
children with ASD range from approximately 52% to 82% compared with 32% to 50% in
children with typical development (Hodge, Carollo, Lewin, Hoffman, & Sweeney, 2014;
Krakowiak, Goodlin-Jones, Hertz-Picciotto, Croen, & Hansen, 2008).
Sleep disturbance is an umbrella term for a range of sleep-related problems
presumably lacking an underlying medical basis, as opposed to sleep disorders. In the
pediatric sleep literature, the sleep disturbance and sleep problems terms are often used
interchangeably (Turner & Johnson, 2012) to refer to common parent-reported sleep
concerns such as bedtime refusal, delayed sleep onset, frequent night awakenings, and
undesired co-sleeping (Blampied & France, 1993). Parents of children with ASD report a

4

BEDTIME FADING WITH RESPONSE COST
variety of disturbed sleep behaviors, such as reduced sleep duration, delayed sleep onset,
early rising, excessive daytime sleep, lack of independent sleep initiation skills, frequent
night waking, difficulty following bedtime routines and undesired co-sleeping
(Christodulu & Durand, 2004; Durand, 2002; Knight & Johnson, 2014; Moon, Corkum,
& Smith, 2010; Piazza, Fisher, & Sherer, 1997; Weiskop, Richdale, & Matthews, 2005).
Notably, these particular sleep problems are not uniquely different than those reported by
parents of typically developing children. It is clear, however, that children with ASD are
affected by disrupted sleep at a much higher frequency and with a much greater severity
than their typically developing peers (Anders, Iosif, Schwichtenberg, Tang & GoodlinJones, 2011; Hodge, Carollo, Lewin, Hoffman, & Sweeney, 2014; Krakowiak, GoodlinJones, Hertz-Picciotto, Croen, & Hansen, 2008; Owens & Whitmans, 2004).
Parents’ report that their child’s sleep problems exacerbate difficulties with social
functioning, mood, and fatigue (Lopez-Wagner, Hoffman, Sweeney, Hodge, & Gilliam,
2008), which may, in turn, decrease the child’s quality of life and limit independent
functioning. Sleep problems in children with ASD can also have detrimental effects on
the entire household (Patzold, Richdale, & Tonge, 1998; Tilford, et al., 2015). When
children do not sleep, it often means that their siblings and parents do not sleep, either.
Parents of children with ASD who sleep poorly during the previous night are likely to
have an increased negative affect/decreased positive affect the following day (Mihaila &
Hartley, 2016). Additionally, mothers who experience chronic poor sleep perceive their
child’s behavior problems as occurring at a higher frequency and severity and/or their
own parenting skills as less effective (Mihaila & Hartley, 2016).
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Parents of children with ASD experience higher levels of stress and depression
and lower levels of marital intimacy than parents of children with and without other
disabilities (Fisman, Wolf, & Noh, 1989; Levin & Scher, 2016; Tilford, et al., 2015).
Parents of children with ASD report a lack of time for family activities, recreation, and
for each other, which can negatively impact the quality of marriage (Fisman, Wolf, &
Noh, 1989). This may explain why sleep disturbances experienced by children with ASD
often result in increased family stress, marital discord, and decreased parental intimacy
(Goodlin-Jones, Tang, Liu, & Anders, 2008; Fisman, Wolf, & Noh, 1989; Hoffman, et.
al., 2008; Mihaila & Hartley, 2016; Meltzer, 2011; Patzold, Richdale, & Tonge, 1998;
Piazza & Fisher, 1991b; Tilford, et al., 2015).
Treatment
Pharmacological agents in conjunction with behavioral intervention are often
recommended for the treatment of sleep disturbance in children with ASD (Johnson &
Malow, 2008). Medications prescribed to children with ASD to treat sleep disturbance
include synthetic melatonin, benzodiazepines, clonidine, beta-blockers, as well as
antipsychotics as a means to counter undesired motor effects (Murray, et. al., 2014).
Melatonin is a naturally occurring hormone released by the pineal gland to help promote
and maintain the circadian rhythm. Synthetically derived melatonin is widely available in
the United States as an over-the-counter supplement (Bramble & Feehan, 2005) and is
used as a first-line treatment for promoting sleep in children on the autism spectrum
(Malow & McGrew, 2008).
To date, the use of behavioral principles (Jin, Hanley, & Beauliue, 2013; Knight
& Johnson, 2014; Turner & Johnson, 2012; Vriend, Corkum, Moon, & Smith, 2011) or
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melatonin (Malow, et al., 2012; Rossignol & Frye, 2011) to address behavioral sleep
disturbances in children with ASD has been explored in 16 and 10 studies, respectively.
Of the melatonin studies, two represent retrospective reviews of records (Andersen,
Kaczmarska, McGrew, & Malow, 2008; Gupta & Hutchins, 2005) and six combine the
implementation of behavioral principles with the delivery of melatonin (Garstang &
Wallis, 2006; Giannotti, Cortesi, Cerquiglini, & Bernabei, 2006; Malow, et al., 2012;
Paavonen, Nieminen-von Wendt, Vanhala, Aronen, & von Wendt, 2003; Wasdell, et. al.,
2008; Wright, et. al., 2010). Only two studies have evaluated melatonin administration
alone without concomitant use of behavioral methods, and one of them is a brief case
study (Jan, Freeman, Wasdell, & Bomben, 2004; Wirojanan, et. al., 2009).
Melatonin has been shown to improve sleep outcomes in children with ASD by
reducing sleep onset latency (Dodge & Wilson, 2001), and increasing total sleep time
(Wirojanan, et. al., 2009). The sustainability of such benefits, once the medication is
withdrawn, has yet to be evaluated. Research results indicate that melatonin does not
have an effect on the parental concerns of frequency of night awakenings (Dodge &
Wilson, 2001; Wirojanan, et al., 2009). Moreover, lacking is the evaluation of melatonin
as a treatment option for other disruptive sleep behaviors that parents have identified as
their primary concern (e.g., bedtime resistance and undesired co-sleeping) (Christodulu &
Durand, 2004; Weiskop, Matthews, & Richdale, 2001; Weiskop, Richdale, & Matthews
2005).
At this time, there is no established dosage or recommended length of use of
melatonin in addressing sleep problems in children with ASD (Kennaway, 2015; Malow,
et al., 2012; Rossignol & Frye, 2011). Some children with ASD may experience poor
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metabolism and disappearing effects of melatonin, leading to potential dose escalation
(Braam, et al., 2012). Similar to other pharmacological agents, melatonin falls short for
many parents because taking a medication does not teach healthy sleep behaviors to
ensure lasting change (Malow & McGrew, 2008). Therefore, research on the exclusive
use of melatonin to improve sleep disturbances in children, with and without ASD,
remains limited and needs to be more rigorously evaluated (Kennaway, 2015).
In the field of behavioral sleep medicine, interventions are based on the principles
of learning that employ methods of reinforcement, contingency management, shaping,
and extinction to teach healthy and appropriate sleep behaviors that last a lifetime.
Interventions with a validated body of research to support their utility, referred to as
empirically supported treatments (ESTs), are considered first-line treatments in
behavioral sleep medicine. The ‘gold standard’ criteria for determining the validity of
such interventions were first established by members of the American Psychological
Association Division 12 task force (Chambless & Ollendick, 2001). These criteria
include definitions of “well established”, “probably efficacious”, and “promising”
interventions, which function as guidelines for determining and choosing the best
available ESTs (Chambless, Baker, Baucom, Beutler, Calhoun, Crits-Christoph, et al.
1998; Chambless & Hollon, 1998; Powers, 1999).
Behavior-based treatments are considered best practice in addressing sleep
problems in typically developing children due to significant improvements experienced
by 80% of children treated (Mindell, Kuhn, Lewin, Meltzer, & Sadeh, 2006). At this
time, research indicates that behavioral interventions for the treatment of sleep problems
in children with ASD have yet to be classified as well established or probably efficacious
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(Schreck, 2001; Vriend, Corkum, Moon, & Smith, 2011). This may be due to insufficient
methodological rigor, lack of significant or equivalent outcomes, and/or the absence of
duplicated studies by more than one investigator or research group that is needed to meet
classification requirements.
Behavioral interventions addressing sleep problems in children with ASD include
bedtime routine (Piazza, Fisher, & Sherer, 1997; Weiskop, Richdale, & Matthews, 2005);
extinction (Durand, Gernert-Dott, & Mapstone, 1996; Weiskop, Matthews, & Richdale,
2001; Wolf, Risley, & Mees, 1964); scheduled awakenings (Durand, 2002); sleep
restriction (Christodulu & Durand, 2004; Durand & Christodulu, 2004); stimulus fading
(Christodulu & Durand, 2004; Howlin, 1984); chronotherapy (Piazza, Hagopian, Hughes,
& Fisher, 1998); parent education (Malow, et al., 2014; Moon, Corkum, & Smith, 2010;
Weiskop, Matthews, & Richdale, 2001); bedtime fading with (Moon, Corkum, & Smith,
2010; Piazza, Fisher, & Sherer, 1997) and without response cost (DeLeon, Fisher, &
Marhefka, 2004); as well as multi-component treatment packages (Jin, Hanley, &
Beauliue, 2013; Knight & Johnson, 2014; Montgomery, Stores, & Wiggs, 2004; Reed, et
al., 2009). Among behavioral interventions, most tend to address one specific sleeprelated behavior at a time (Piazza & Fisher, 1991b), such as night terrors (Durand, 2002);
disrupted sleep-wake cycle (Piazza, Hagopian, Hughes, & Fisher, 1998), and excessive
daytime sleepiness (Friedman & Luiselli, 2008). In reality, parents of children with ASD
tend to report a multitude of co-occurring sleep problems (e.g., bedtime resistance,
delayed sleep onset, frequent night waking, and undesired co-sleeping) (Christodulu &
Durand, 2004; Durand & Christodulu, 2004; Durand, Gernert-Dott, & Mapstone, 1996;
Reed, et. al., 2009; Weiskop, Matthews, & Richdale, 2001).
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Parents of children with ASD report that some sleep disturbances evolve from
their own attempts to address other long-standing sleep problems, such as engaging in
undesired co-sleeping to reduce night awakenings (Reed, et al., 2009). Undesired cosleeping can be a part of the initial bedtime routine (Weiskop, Matthews, & Richdale,
2001; Weiskop, Richdale, & Matthews, 2005) or a response to difficulty falling back
asleep and disruptive behaviors (i.e., tantrums, refusal to sleep in own bed, or escaping
from the bed and bedroom) following night awakenings (Christodulu & Durand, 2004;
Durand & Christodulu, 2004; Durand, Gernert-Dott, & Mapstone, 1996; Howlin, 1984).
Therefore, it is not surprising that undesired co-sleeping experienced by children with
ASD often coincides with a wide variety of sleep problems, including frequent night
awakenings, bedtime disturbances, difficulty falling asleep and reinitiating sleep
independently, decreased duration of sleep, early morning awakenings, and refusal to
sleep in one’s own bed (Christodulu & Durand, 2004; Durand & Christodulu, 2004;
Durand, Gernert-Dott, & Mapstone, 1996; Howlin, 1984; Reed, et. al., 2009; Weiskop,
Matthews, & Richdale, 2001; Weiskop, Richdale, & Matthews, 2005).
Bedtime Fading with Response Cost (BFRC) is a promising behavior-based
intervention that targets a multitude of sleep problems concurrently (Piazza, Fisher, &
Sherer, 1997). Specifically, BFRC has been demonstrated to decrease disruptive sleeprelated behaviors, reduce sleep latency, reduce night awakenings, and increase sleep
duration in children with ASD (DeLeon, Fisher, & Marhefka, 2004; Moon, Corkum, &
Smith, 2010; Piazza, Fisher, & Moser, 1991; Piazza, Fisher, & Sherer, 1997). BFRC has
also been effective in reducing (Piazza & Fisher, 1991b; Piazza, Fisher, & Moser, 1991)
and even eliminating (Ashbaugh & Peck, 1998) undesired co-sleeping in children without
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ASD. Thus far, undesired co-sleeping has not been the primary sleep variable in studies
evaluating BFRC with children on the autism spectrum. To date, undesired co-sleeping
has been used as the primary dependent variable in only two studies (Weiskop,
Matthews, & Richdale, 2001; Weiskop, Richdale, & Matthews, 2005) in children with
ASD. Both studies focused on parent-defined sleep disturbances and treatment goals.
Original BFRC Protocol
BFRC involves temporarily delaying the child’s typical bedtime, establishing a
set wake-time (regardless of the amount of sleep acquired the night before), and
eliminating access to daytime sleep (for non-napping children ages 4 and older) (Piazza
& Fisher, 1991b). Developmental sleep norms in conjunction with parent sleep goals are
used to set the appropriate bedtime and wake-time based on the amount of sleep required
for each child. Parents are informed of the average hours of sleep per night needed by
their child according to his or her chronological age and asked to indicate their preferred
time of sleep onset, awakening, and nap (if applicable). The original BFRC protocol
began with collecting baseline data on whether the child was asleep or awake every 30
minutes, throughout a 24-hour period, until data were determined stable. Once baseline
data are stable, the child’s mean sleep onset time was calculated and the child’s bedtime
was temporarily delayed by adding 30 minutes to the average time the child typically fell
asleep (i.e., faded bedtime) (Piazza & Fisher, 1991b). For example, if the child’s average
time of sleep onset was10:45 p.m. during baseline, the initial bedtime was set to
11:15pm.
The caregivers placed the child in bed at the scheduled bedtime and observed the
child 15 minutes later to determine whether the child was asleep or awake. A caregiver
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stood within one foot of the child and whispered his or her name. If the child did not
respond to his or her name (i.e., the absence of motor or verbal response), then the child
was considered to be asleep, and the caregiver recorded the time of sleep onset. If the
child was not asleep, he or she was removed from his or her bed, and restrict access to the
bed, bedroom, and sleep for 45 minutes (i.e., response cost). During that time, the child
was allowed to partake in regular nighttime activities (e.g., play with toys, watch TV) not
related to sleep. At the end of the 45 minutes the child was returned to bed. If the child
did not fall asleep within 15 minutes of being returned to bed, the caregivers repeated the
response cost procedure by removing the child from bed for 45 minutes and allowed the
child to engage in non-sleep related activities. This procedure was repeated until the child
fell asleep within 15 minutes of being placed in bed (Piazza & Fisher, 1991b).
Each subsequent night the child’s bedtime was adjusted by 30 minutes based on
the time of sleep onset during the previous night. For example, if bedtime was 10:30
p.m., and the child did not fall asleep until 12:00 a.m., the following night the bedtime
would be 11:00 p.m.; similarly, if the child fell asleep at 10:30 p.m., the following night
the bedtime would be adjusted to 10:00 p.m. For instances of nighttime awakenings,
caregivers were encouraged to prompt the child to return to his or her bed every 30
minutes. Caregivers allowed the child to engage in regular nighttime activities. The
predetermined wake-time was strongly enforced by the caregivers every day, regardless
of the amount and quality of the child’s sleep during the previous night. Caregivers
eliminated access to daytime sleep, unless naps were appropriate for the age and
developmental needs of the child (Piazza & Fisher, 1991b).
BFRC Procedural Variants
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Modifications to the original BFRC protocol have been reported in subsequent
studies (Ashbaugh & Peck, 1998; DeLeon, Fisher, & Marhefka, 2004; Moon, Corkum, &
Smith, 2010; Piazza, Fisher, & Sherer, 1997). Variations include the amount of time the
bedtime is faded, the duration of time allowed to achieve sleep before response cost is
implemented, the duration of the response cost procedure itself, and the duration of faded
bedtime. The amount of time added to the faded bedtime and the duration of response
cost, i.e., time spent out of bed when not achieving sleep onset, have been evaluated
using both 30- and 60-minute intervals. The amount of time allotted between placing a
child in bed and checking sleep onset has included both 15- and 20-minute intervals.
Fading the bedtime once sleep onset is achieved has been evaluated with both 15- and 30minute intervals and after either one or two consecutive nights. In addition, the original
authors of BFRC suggest fading the bedtime by 15 minutes, rather than 30 minutes, if the
child’s bedtime fading plateaus (does not progress) before reaching the bedtime goal
(Piazza & Fisher, 1991b). With and without modifications to the original protocol, BFRC
has been shown to be effective in addressing various co-occurring sleep disturbances with
a typically developing child (Ashbaugh & Peck, 1998), children with intellectual
disability (ID) (Piazza & Fisher, 1991b), children with autism (DeLeon, Fisher, &
Marhefka, 2004; Moon, Corkum, & Smith, 2010; Piazza, Fisher, & Sherer, 1997) and
related disorders (Piazza, Fisher, & Moser, 1991).
BFRC and Children with Non-ASD Neurodevelopmental Disorders
The bedtime fading procedure without the response cost component was first
developed by Piazza and Fisher (1991a) to increase the duration of appropriate nighttime
sleep of two children with severe sleep problems. Treatment included utilizing baseline
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data of each participant’s average time (i.e., within 15 minutes) of sleep onset that was
most likely to occur. Faded bedtime was then determined by calculating the baseline
average for sleep onset and adding one half hour. For example, if the average sleep onset
time is 10:00 p.m. during baseline, then the initial bedtime during the treatment phase is
10:30 p.m. Treatment required the child to remain awake until the faded bedtime and
access to the bed was not permitted until the designated bedtime. Additionally, a
predetermined wake time was established and the participant was not allowed to sleep
past this time (Piazza & Fisher, 1991a). Based on the previous night’s time of sleep onset,
the bedtime was adjusted accordingly, such that if the child fell asleep within 15 minutes
of the designated bedtime, the bedtime was adjusted 15 minutes earlier. Correspondingly,
if the child did not fall asleep within the allotted 15 minutes, the bedtime was pushed
later an additional 15 minutes. Bedtime adjustment required two consecutive nights of the
same established sleep onset time before fading the bedtime on the third night.
Two participants, a 6-year-old female diagnosed with attention deficithyperactivity disorder (ADHD) and a 4-year-old female diagnosed with profound ID and
comorbid tuberous sclerosis were included in the study (Piazza & Fisher, 1991a). Both
participants experienced multiple sleep problems, including bedtime refusal, bedtime
disruption, and a lack of independent sleep initiation. The 6-year-old participant
experienced frequent night awakenings and obtained only four to six hours of sleep per
night. Treatment was initiated while the participant lived at home with her grandmother.
The 4-year-old participant experienced excessive daytime sleepiness and fell asleep
multiple times during the day. Treatment was conducted while the participant resided at
an inpatient facility for children with developmental disabilities. A momentary time
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sampling procedure (every 30 minutes during a 24-hour cycle) was utilized to record
whether the child was in or out of bed and awake or asleep. Trained observers collected
data on the participant in the inpatient unit. The grandmother of the in-home participant
collected data until she went to bed, with the addition of two scheduled checks at 2:00
a.m. and 4:00 a.m. (Piazza & Fisher, 1991a).
Results indicate that bedtime fading procedure increased the percentage of
appropriate sleep (i.e., hours of sleep occurring within the determined timeframe) and
increased the duration of sleep for both participants. In addition, bedtime fading
eliminated the problem sleep behaviors of night awakening and bedtime refusal for the 6year-old participant. The authors suggested that bedtime fading is potentially useful for
combating multiple sleep problem concurrently as it may help to institute a consistent
sleep cycle and establish the bed as a conditioned reinforcer for sleep (Piazza & Fisher,
1991a). One limitation of the study was that the authors did not use an objective measure
(e.g., actigraphy) of the participants’ target behaviors. Skill acquisition and the
elimination of problem sleep behaviors were based on observers’ and caregiver reports.
The same authors were the first to evaluate bedtime fading with the added
component of response cost (BFRC) (Piazza & Fisher, 1991b). The additional treatment
component included removing the child from bed and keeping him or her awake for one
hour if sleep was not initiated within 15 minutes of the initial bedtime. During the hour of
response cost, the child was permitted access to the same items and attention as found
during baseline. At the end of the one-hour interval, the child was returned to bed and
allowed 15 minutes to fall asleep. If the child did not fall asleep within the allotted
amount of time, he or she was removed from the bed again (i.e., response cost) and
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required to remain awake for an additional hour. The outlined procedure was repeated
until sleep onset was achieved within 15 minutes of being placed in bed. The
investigators hypothesized that the response cost component would “enhance treatment
efficacy” by allowing for “a more rapid fading of the bedtime”, thus increasing the
reinforcing value of sleep (Piazza & Fisher, 1991b).
Participants were four nonverbal children diagnosed with profound ID and living
in an inpatient unit for the treatment of ID and self-injurious behaviors. All participants
experienced co-occurring sleep problems such as delayed sleep onset, inconsistent sleep
duration, night awakenings, early morning awakenings, disruptive bedtime behaviors,
and excessive daytime sleep, whereas one participant experienced undesired co-sleeping.
Similarly to the first bedtime fading study (Piazza & Fisher, 1991a), the investigators
employed a momentary time-sampling (e.g., each half hour) method conducted by trained
observers to record whether or not the participants were in or out of bed and awake or
asleep. The effectiveness of the procedure was evaluated using a non-concurrent multiple
baseline across subjects. The parameters for the bedtime fading component as found in
the preliminary study were used in the same manner, with the response cost component
previously described (Piazza & Fisher, 1991b).
Two different observers scored the child’s behavior (i.e., awake or asleep, in or
out of bed) to assess inter-observer agreement (IOA). Results of the study indicated that
all participants either improved in the percentage of intervals of appropriate sleep or
decreased in the percentage of intervals of inappropriate sleep. Three out of four
participants demonstrated a decrease in the frequency of night awakenings. Furthermore,
disruptive bedtime behaviors decreased from 100% to 16% for one participant and

16

BEDTIME FADING WITH RESPONSE COST
undesired co-sleeping decreased by nearly 50% for another. The authors concluded that
each participant benefited from the BFRC procedure and that both classical and operant
conditioning may have facilitated treatment efficacy (Piazza & Fisher, 1991b).
A third study, coauthored by Piazza, Fisher, & Moser (1991), sought to evaluate
whether BFRC would be effective in improving the aberrant sleep patterns of three girls
with Rett Syndrome (RS). Standard BFRC procedures were used for all three participants
who were participating in inpatient (N=2) or outpatient (N=1) services for the treatment
of behavior problems. Sleep problems included night awakenings, unwanted co-sleeping,
delayed sleep onset, and excessive daytime sleep. Data recording methods and IOA
employed by the trained observers and parent participants remained consistent with
methods outlined in previous studies (Piazza & Fisher, 1991a; Piazza & Fisher, 1991b).
Results demonstrated an increase in the percentage of appropriate sleep for all
participants, although clinical significance was not determined (Piazza, Fisher, & Moser,
1991). In addition, time of sleep onset decreased for one participant, and the duration of
night awakenings, as well as the percentage of daytime sleep, decreased for two
participants. Outcomes for undesired co-sleeping were not directly reported, although the
authors did indicate that the parents of one participant were engaging in co-sleeping less
frequently and spending less time soothing their child back to sleep. Similarly to the
previous bedtime fading and BFRC studies (Piazza & Fisher, 1991a; Piazza & Fisher,
1991b), no information was provided on how the parent participants were trained to
implement the BFRC procedure or collect data on the observable sleep variables (Piazza,
Fisher, & Moser, 1991). In addition, sleep variables were not measured objectively.
BFRC and Typically Developing Children
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To date, only one study replicated the BFRC procedures with a typically
developing child. Ashbaugh and Peck (1998) employed an ABAB experimental design
with a typically developing 2-year-old female experiencing frequent night awakenings,
disrupted sleep, and undesired co-sleeping. The participant lived at home with her
biological father and mother, the latter being a member of the investigative team.
Ashbaugh and Peck (1998) followed the BFRC protocol and data collection procedures
as presented in the Piazza and Fisher (1991b) study, with two minor modifications: 1)
The procedure included returning the child to her own bed if she awoke during the night,
as requested by her parents; and 2) The response cost component was reduced from 1
hour to 30 minutes. Bedtime for the subsequent night was adjusted earlier by 30 minutes
if the child was able to fall asleep within the allotted 15 minutes or later by 30 minutes if
the child was not able to fall asleep within 15 minutes of bedtime (Ashbaugh & Peck,
1998). Parent and teacher observations of napping behavior were conducted and
compared for IOA. Results of the study indicated that the participant was able to establish
a more regular sleep schedule and undesirable co-sleeping was eliminated. The authors
noted that slight modifications to the BFRC might not diminish the effectiveness of the
intervention (Ashbaugh & Peck, 1998).
BFRC and Children with ASD
Three studies have evaluated the effects of BFRC in children with autism and
sleep disturbance (DeLeon, Fisher, & Marhefka, 2004; Moon, Corkum, & Smith, 2010;
Piazza, Fisher, & Sherer, 1997). All three studies concluded that faded bedtime, with or
without response cost, was successful in improving sleep problems in children with
autism. Piazza, Fisher, and Sherer (1997) compared the relative effectiveness of BFRC to

18

BEDTIME FADING WITH RESPONSE COST
simple bedtime scheduling, which involved establishing a set bedtime and wake time
(naps if age appropriate) and permitting sleep only during designated times. Bedtime
scheduling also included implementing a consistent bedtime routine and placing the child
in bed at the designated times (Piazza, Fisher, & Sherer, 1997). Five of the fourteen
participants, ages 5 to 8 years, were diagnosed with ASD. Participants were randomly
assigned to either the BFRC or the bedtime scheduling group. Treatment took place in an
institutionalized setting as all 14 participants were being treated for severe behaviors in
an inpatient unit (Piazza, Fisher, & Sherer, 1997).
Sleep problems experienced by the sample population included early awakenings,
difficulties initiating sleep independently, delayed sleep onset, and nighttime awakenings.
BFRC procedures, data collections methods, and IOA techniques were adopted from
previously described studies (Piazza & Fisher, 1991b; Piazza, Fisher, & Moser, 1991).
Result indicated that for all participants the BFRC intervention, compared with bedtime
scheduling, produced a greater reduction of sleep problems (Piazza, Fisher, & Sherer,
1997). Of the two children with ASD in the bedtime scheduling group, one showed slight
improvement with night waking and falling asleep, while the other child’s sleep problems
(i.e., night awakening and early awakening) maintained at baseline levels. All three of the
participants with ASD in the BFRC group demonstrated improvements with the near
elimination of early awakenings and a decrease in the duration and frequency of night
awakenings. Outcomes were maintained at a 4-month follow-up. Strength of this study
was the inclusion of a comparison group to demonstrate the effectiveness of BFRC.
A subsequent study evaluated the effectiveness of the faded bedtime component
without response cost in solving sleep problems and preventing self-injurious behaviors
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(SIBs) in a 4-year-old male with ASD (DeLeon, Fisher, & Marhefka, 2004). The
participant awoke frequently throughout the night and engaged in head banging, flopping
on the floor, and body hitting, until receiving contingent reinforcement of attention in the
form of hugs and comfort. Treatment was conducted in an inpatient unit for the treatment
of severe SIBs. BFRC treatment procedures, data collection methods, and IOA criteria
were replicated from previous studies (Piazza & Fisher, 1991b; Piazza, Fisher, & Moser,
1991; Piazza, Fisher, & Sherer, 1997). The investigators employed an AB design without
a reversal condition due to the severe nature of the participants’ SIBs. Results
demonstrated a decrease in the total number of night awakenings, which, in turn, lead to
the reduction in the frequency and rate of the wake-related SIBs displayed by the
participant (DeLeon, Fisher, & Marhefka, 2004).
The most recent BFRC study examined the effectiveness of a manualized BFRC
program in the reduction of problem sleep behaviors in children with ASD (Moon,
Corkum, & Smith, 2010). All participants (N=3) had a diagnosis of ASD, lived at home
with their biological families, and experienced delayed sleep onset and difficulties with
initiating sleep. The parents of all participants were trained to provide the BFRC
procedure at home. Each parent received a handbook on the treatment of sleep
difficulties, including information on the principles of sleep hygiene, importance of
consistent bedtime routines, and behavioral strategies for managing child’s daytime and
sleep-related behaviors. Parents met with a therapist for 5 consecutive weeks to review
the information provided in the handbook. In addition, at the end of each week, the
therapist contacted parents by phone to review the content of the materials learned and to
monitor progress (Moon, Corkum, & Smith, 2010).
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The BFRC procedure, data collection method, and IOA criteria remained the
same as described in preceding studies (Piazza & Fisher, 1991b; Piazza, Fisher, & Moser,
1991; Piazza, Fisher, & Sherer, 1997) with minor exceptions: The duration of time
allowed to attain sleep onset was increased from 15 minutes to 20 minutes (Moon,
Corkum, & Smith, 2010). Sleep diaries and actigraphy were used to record sleep
outcomes. Results indicate a reduction in sleep onset latency for all three participants.
Outcomes were maintained at a 12-week follow-up, and parents reported satisfaction with
the intervention. Strengths of this study include objective recording of sleep variables
(i.e., actigraphy), clear use of behavioral definitions needed to replicate the study, and
engaging parents to implement the BFRC protocol in the home environment (Moon,
Corkum, & Smith, 2010). A weakness of the study is that it is impossible to isolate BFRC
as the only independent variable when the intervention was presented in combination of
other treatment strategies, such as the didactic sessions and handbook on behavioral
strategies. As a result, the study makes it difficult to determine if treatment outcomes are
the result of the BFRC intervention itself.
Conclusion and Future Directions
In summary, children with ASD experience various co-occurring sleep problems
and disruptive sleep-related behaviors at a greater frequency and severity than typically
developing children. Consequently, in children with ASD and their families quality of life
and day-to-day functioning suffer. Parents of children with ASD who also experience
sleep disturbances are especially at risk for mood disorders and marital dissatisfaction.
Effective behavioral treatments that parents can reliably implement at home are limited.
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BFRC is a promising intervention that successfully addresses sleep problems and sleeprelated problem behaviors in children with and without ASD.
At this time, BFRC has been restricted to controlled studies by several groups of
investigators implemented by trained professionals in institution settings. Consideration
has yet to be given to how parents uniquely define sleep disturbance within the context of
their own home and family. Primary sleep variables tend to be researcher defined, which
may not capture the most salient aspects of a child’s sleep disturbances from the parent’s
perspective. For example, undesired co-sleeping is a commonly occurring sleep
disturbance reported by parents of children with ASD. However, parent-defined primary
dependent variables have not been considered in any of the existing BFRC studies. Only
one BFRC study engaged parents in implementing treatment of sleep problems in
children with ASD in the home setting. However, none of these studies utilized parentderived sleep goals to determine the onset of treatment or evaluate the effectiveness of
BFRC for the reduction of sleep disturbance in children with ASD. Therefore, the
primary purpose of this study was to evaluate the effectiveness of BFRC as a parentimplemented home-based treatment for parent-defined sleep disturbances and related
sleep problems experienced by their child with ASD.
Method
Participants
Children between ages 4 and 8 years with a clinical diagnosis of autism and sleep
disturbance were recruited through a day treatment program for children with ASDs and
an outpatient behavioral health clinic located in the Midwest. Participant recruitment
continued until a sufficient number of eligible participants (N=3) needed for a single
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subject research design was recruited. Participant selection criteria were adapted from
other studies in the area of behavioral treatment of sleep disturbance in children (Mindell
& Durand, 1993; Weiskop, Richdale, & Matthews, 2005). Recruited participants had a
confirmed diagnosis of autism based on the Autism Diagnostic Observation Schedule,
Second Edition (ADOS-2) (Lord, et al. 2012) and the Childhood Autism Rating Scale,
Second Edition (CARS-2) (Schopler, Van Bourgondien, Wellman, & Love, 2010), which
is standard practice in diagnostics. For the purposes of this study, individuals with a
classification of Autism or Autism Spectrum on the ADOS-2, in combination with a
classification of either Severe or Mild-to-Moderate on the CARS-2, met the criteria for a
diagnosis of autism and were deemed eligible for participation in the study. Individuals
classified as Non-Spectrum on the ADOS-2 and/or Minimal-to-No-Symptoms on the
CARS-2 were excluded from the study. Eligible participants were required to be living at
home with at least one parent at the time of the study and present with a minimum of
four-week history of childhood sleep disturbances as denoted by
▪

resistance to going to bed, defined as one or more verbal protests and/or
physical protests a night, for a minimum of three nights per week; or

▪

delayed sleep onset, defined as more than 20 minutes between bedtime and
falling asleep, for a minimum of three nights per week; or

▪

any of the following situations at bedtime for a minimum of three nights per
week:
•

undesired co-sleeping with a parent or sibling, being rocked or held to
fall asleep, falling asleep in a location other than his/her own bed; or

•

falling asleep with a bottle or pacifier; or
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•

spontaneous awakening that requires parental intervention to return to
sleep at least once per night, at least three times per week.

Children using pharmacological agents to regulate sleep and/or other behaviors
were not necessarily excluded. Unless medically necessary, parents were asked to
attempt to maintain their child’s medication regiment throughout the duration of
the study. Excluded from the study were families who had received professionally
derived information directly from a psychologist, therapist, and/or physician
and/or used a behavior-based intervention to address their child’s sleep problems
within the past 6 months (Moon, Corkum, & Smith, 2010).
Three potential participants were screened and met criteria for participation. All
three parents-child dyads enrolled and completed the study. All three children had been
diagnosed with ASD prior to enrolling in the study. Each participant met the
classification of Autism on the ADOS-2 and the Severe Symptoms of Autism Spectrum
Disorder group on the CARS-2 measures. All names were changed to protect
participants’ right to confidentiality. Participant 1, Bill, was a 7-year-old Caucasian male
attending the 1st grade. Bill’s parents reported that he exhibited bedtime resistance,
refused to sleep in his own bed, and took longer than 20 minutes to fall asleep each night.
He woke repeatedly throughout the night and each time sought parental presence to
reinitiate sleep by crawling into his parents’ bed. His parents often engaged in undesired
co-sleeping with Bill in their bed, as they were asleep when he crawled into their bed and
remained asleep with Bill in bed. Participant 2, Holly, was an 8-year-old Caucasian
female attending the 3rd grade. Her parents reported that she refused to sleep in her own
bed and never fell asleep without parental presence. A parent had to remain next to Holly
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each night in their bed and engaged in undesired co-sleeping to get her to fall asleep.
Participant 3, Keith, was a 4-year-old Caucasian male attending preschool. His parents
reported that he resisted bedtime, had difficultly falling asleep, and experienced frequent
awakenings throughout the night. Keith required parental presence to fall asleep at
bedtime and following any night awakening, which resulted in undesired co-sleeping in
either his bed or his parents’ bed. His parents reported that Keith sometimes stayed
awake throughout the entire night.
All children were living with their biological parents and siblings. Each parent
reported participating in implementing the BFRC protocol, whereas one designated
parent from each dyad was responsible for collecting data and taking telephone calls from
a member of the investigative team. During the study, all children continued their
previously prescribed regiment of medication (Bill: dexmethylphenidate [Focalin],
guanfacine, and melatonin; Holly: risperidone and melatonin; Keith: cetirizine [Zyrtec]).
Table 1 provides a summary of participant characteristics including chronological age,
gender, ADOS-2 scores and classification, CARS-2 scores and severity group, and sleep
problems meeting selection criteria.
Materials
A trained clinician administered the ADOS-2 and CARS-2 to evaluate each child’s
verbal, social, and cognitive abilities (Gotham, Risi, Pickles, & Lord, 2007). The ADOS-2
is a semi-structured, standardized assessment for children ages 12 months through
adulthood that allowed the examiner to observe and rate behaviors related to
communication and social interaction and play skills identified as important to the
diagnosis of ASD. Scores based on the examiner’s observations were calculated through
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the use of a diagnostic algorithm to yield one of three classifications (i.e., Autism, Autism
Spectrum, and Non-spectrum) (Lord, et al., 2012). The use of the ADOS-2 alone does not
provide justification for a diagnosis of ASD; therefore, the CARS-2 was used as a
screening tool to compliment ADOS-2 outcomes.
The CARS-2 is a valid and reliable clinician- and parent-completed rating scale
for children ages 2-13 years (Schopler, Van Bourgondien, Wellman, & Love, 2010). The
CARS-2 is comprised of descriptors of childhood social, developmental, and motor
abilities related to ASD symptoms. A total score classifies children into one of three
severity groups of ASD symptoms (i.e., Severe, Mild-to-Moderate, and Minimal-to-NoSymptoms).
Dependent measures of sleep included the following: (a) Sleep Diary; (b)
Actigraphy; (c) Behavior Diary; and (d) the Children’s Sleep Habit Questionnaire
(CSHQ). All measures were collected during baseline (4 to 14 days), end of treatment (11
to 14 days), and at one month post-treatment (4 to 7 days). A Sleep Diary is a
standardized parent-completed measure in the field of behavioral interventions and sleep
medicine with a reasonable validity and high internal consistency (Corkum, Tannock,
Moldofsky, Hogg-Johnson, & Humphries, 2001; Mindell & Durand, 1993).
A traditional sleep diary, based on considerations from the literature (Patzold,
Richdale, & Tonge, 1998; Weiskop, Matthews, & Richdale, 2001), was developed for
this study. One parent per family recorded nightly information regarding their child’s
sleep in the sleep diary throughout the duration of the study (see Appendix A). Outcomes
recorded in the diary specific to sleep included (a) frequency and duration of night
awakenings after sleep onset (FNA; WASO); (b) sleep onset latency (SOL); (c) total
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sleep time (TST); (d) time in bed (TIB); and (e) independent versus dependent sleep
initiation (ISO; DSO). Sleep efficiency (SE) outcomes were extrapolated from the sleep
diary data [(TST/TIB) x 100] and expressed as a percentage.
A slightly modified sleep-related behavior diary (Allen, Kuhn, DeHaai, &
Wallace, 2013; Burke, Kuhn, & Peterson, 2004) was added to this study. The same parent
recorded nightly information regarding their child’s sleep-related behaviors in the
behavior diary throughout the duration of the study (see Appendix B). Diary outcomes
specific to sleep-related behavior included (a) frequency and duration of undesired cosleeping (UC-S) with a parent or a sibling; (b) frequency and duration of bedtime
resistance (BR; DBR); (c) frequency of sleeping in a non-designated area; and (d) the
location of non-designated sleep (refer to Table 2 for a list of all dependent variables on
the sleep and sleep related behavior diaries). Bedtime resistance (BR) frequencies were
the sum total of the number of disruptive behaviors that occurred during the bedtime
routine once the child was placed in bed and the number of times the child got out of the
bedroom after being put in bed for the night. Disruptive Behavior Composite (DBC)
mean frequency was determined by dividing the sum total of BR per data collection
phase by the number of days during that period. Duration of bedtime resistance (DBR)
outcomes were obtained by calculating the duration of disruptive behaviors during
bedtime routine and once the child was placed in bed with the duration of time the child
was out of the bedroom after being put in bed for the night.
Treatment integrity is a measure of the extent to which treatment procedures are
implemented as intended (Vollmer & Sloman, 2008). An integrity-monitoring sheet on
the BFRC protocol (see Appendix C) was created for this study based on clinical
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considerations and the literature (Burke, Kuhn, & Peterson, 2004; Durand & Mindell,
199b; Vollmer & Sloman, 2008). Telephone calls were made to the designated parent
responsible for data collection at least three times a week during the treatment phase
(Burke, Kuhn, & Peterson, 2004; Durand & Mindell, 1999b). On randomly selected
nights, parents answered a series of questions related to components of the BFRC
procedure they implemented. Parent responses were recorded on the integrity-monitoring
sheet, and a random sample of data collected, ranging from 43% to 71% of participant
treatment data, was scored for fidelity. Treatment integrity outcomes were calculated by
dividing the sum of correct parent responses by the total number of possible correct
responses and multiplying the result by 100 (Vollmer & Sloman, 2008). The bedtime
fading components were implemented with 96% integrity for Holly, 97% integrity for
Bill, and 100% integrity for Keith. The response cost components were implemented with
100% integrity for all three participants.
To assess the reliability of data collection, periodic telephone checks were used to
compare the level of agreement between parent-reported data and actual recorded data for
the previous one to three nights during the treatment phase (Burke, Kuhn, & Peterson,
2004; Durand & Mindell, 1999b). The researcher recorded parent verbal reports during
each telephone check using a blank sleep diary and sleep-related behavior diary (see
Appendix A and B). Random samplings of these telephone checks (i.e., 43% of data for
Keith, 50% for Bill, 71% for Holly) were later matched and compared with the data
forms returned by parents. Data points were considered reliable if the difference between
the reported and recorded durations varied by no more than 15 minutes and observed
frequencies varied by no more than one point between data sets (Burke, Kuhn, Peterson,
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2004). Reliability was calculated by dividing the sum of agreements by the sum total of
agreements plus disagreements and multiplying the result by 100 [(∑ of agreements / [∑
of agreements + ∑ of disagreements]) x 100]. The result was expressed as a percentage
(Durand & Mindell, 1999b). Level of agreement between the telephone checks and
parent-recorded sleep diaries was 95% for Holly, and 97% for Bill and Keith each. The
level of agreement between parent-recorded sleep-related behaviors was 94% for Holly,
98% for Keith, and 100% for Bill.
Actigraphy is an objective measure of motor activity, which, in turn, provides
reliable estimates of sleep-wake patterns in children (Meltzer, Montgomery-Downs,
Insana, & Walsh, 2012). Actigraphy is considered a relatively unobtrusive method for
recording sleep patterns in children. Children with autism and/or sensory issues may not
tolerate wrist placement of the actigraph device; therefore, ankle placement is
recommended (Ancoli-Israel, et al. 2015). The MicroMini Motionlogger actigraph
(Ambulatory Monitoring, Inc.), a small sensor about the size of a wristwatch, was
secured with a hospital band to each child’s ankle to continuously record movement.
Parents were asked to have their child constantly wear the small actigraph on the same
ankle, except during bathing or swimming. Zero Crossing Mode (ZCM) was used to
count frequencies of signal-based movement for each epoch (e.g., 30 seconds or one
minute). Activity data collected were downloaded from the sensor using Act Millennium
(version 3.68.0.1) software. Data were scored using Action W (version 2) software and
the Sadeh scoring algorithm (Sadeh, Sharkey, & Carskadon, 1994) to make inferences
about the child’s sleep-wake cycles. Primary outcome variables included SOL, TST, SE,
WASO, and TIB.
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The Children’s Sleep Habits Questionnaire (CSHQ) (Owens, Spirito, &
McGuinn, 2000) is a widely used multidimensional measure to determine the frequency
and topography of sleep behaviors for school-aged children between 4-10 years. The
parent-completed questionnaire yields reliable psychometric properties with typically and
non-typically developing children (Lewandowski, Toliver-Sokol, & Palermo, 2011).
CSHQ abbreviated version (CSHQ-A) is composed of 33 items regarding bedtime, sleep
behaviors, waking during the night, and morning waking/daytime sleepiness (Owens,
Spirito, & McGuinn, 2000). Parents retrospectively reported their child’s sleep for the
past week using a Likert scale indicating if the problem occurred “usually” (five to sever
nights per week), “sometimes” (two to four nights per week), or “rarely” (zero to one
night per week). Parents also indicated if the sleep habit was a problem by circling “Yes”,
“No”, or “Not applicable (N/A)”. Items were scored within 8 subscales (i.e., bedtime
resistance, sleep onset delay, sleep duration, sleep anxiety, night awakenings,
parasomnias, sleep disordered breathing, and daytime sleepiness). Total sum of each
subscale yielded a total sleep disturbance score (range of 33 to 87), with a proposed cutoff score of 41; higher scores indicate more sleep problems.
Three measures were selected to capture the impact of and satisfaction with
treatment for the family. The Goal Achievement Scale (GAS) quantifies progress on
parent-identified treatment goals and assesses the clinical significance of change in sleep
behavior (Hudson, Wilken, Jauering, & Raddler, 1995). For each identified treatment
goal (i.e., sleep related behavior), 0% success (i.e., no improvement) was the set baseline
rate. Before treatment, parents (with guidance from a member of the research team on
developmentally appropriate behaviors) decided what would constitute 100% (total)
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success for each goal. Success was dependent on the parents’ level of desired
improvement, not on the total elimination of a problem behavior. Change in each goal
was expressed as a percentage of success over baseline. For example, parents reported
wanting to reduce the frequency of co-sleeping. Parents’ goals represented a personally
acceptable level of co-sleeping (e.g., 2 out of 7 nights per week). Baseline rate of
undesired co-sleeping (e.g., occurring 7 out of 7 nights per week) was set at 0% success,
whereas the goal for 100% total success depended on parents’ preference (e.g.,
eliminating all but 2 of the 7 nights of co-sleeping per week).
The Parent’s Customer Satisfaction Questionnaire (PCSQ) is a 42-item
questionnaire to evaluate treatment satisfaction (McMahon & Forehand, 2003). For the
purposes of this study, only 16 questions specific to treatment satisfaction were used; 11
items corresponded to a Likert scale (e.g., 1 (considerably worse) to 7 (greatly
improved)). Wording of each response option varied according to the question being
asked (e.g., 1 = Very dissatisfied to 7 = Very satisfied; 1 = Strongly not recommended to 7
= Strongly recommended; 1 = Very inappropriate to 7 = Very appropriate; 1 = Very
pessimistic to 7 = Very optimistic). Parents evaluated the overall treatment protocol by
rating the degree to which they endorsed each statement and answered 5 open-ended
questions related to usefulness of the treatment.
The Kansas Marital Satisfaction Scale (KMSS) is a brief 3-item measure designed
to rapidly assess relationship satisfaction of married individuals or couples (Crane,
Middleton, & Bean, 2000). The KMSS is described as a “reliable and economical” tool
for measuring satisfaction with marriage, partners, and marital relationships. Parents
separately completed the KMSS by reading each item and marking on the corresponding
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scale of 1 (extremely dissatisfied) to 7 (extremely satisfied) the degree to which they
agreed with each statement (Schumm, Nichols, Schectman, & Grigsby, 1983). A possible
score for each item ranges from 1 to 7; a cut-off score of 17 distinguishes between
distressed and non-distressed couples, with a total individual score of 16 or lower
indicating marital distress (Crane, Middleton, & Bean, 2000).
Procedure
Initial Interview
Parents of prospective participants completed a 15-minute telephone screening
followed by a face-to-face interview to determine eligibility. During this interview,
parents and children met with a member of the investigated team to complete the CARS2, baseline CSHQ-A, and a demographic questionnaire. A classification of either Severe
or Mild-to-Moderate ASD resulted in the administration of the ADOS-2. Depending on
parents’ availability, the ADOS-2 was completed either during the initial session or
scheduled for another time that week. Parents were invited to participate in the study
once a diagnosis of autism was confirmed and all other eligibility criteria were met. The
consent form was reviewed and parents completed the KMSS.
Pre-Baseline
Prior to baseline data collection, parents meet with a member of the investigative
team for a second session to identify their specific treatment goals. Parents were
instructed in the recording of data in the sleep and behavior diaries. They received
feedback from a trained clinician as they completed sample diaries for two vignettes
describing detailed sleep patterns and sleep-related behaviors (see Appendix D). Once
parent dyads correctly completed the sample diaries, they were provided blank diaries
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and an actigraph to begin collection of data on their child’s sleep patterns and sleeprelated behaviors (Christodulu & Durand, 2004; Reed et al, 2009).
Baseline
Parents met with a member of the investigative team once a week during the
baseline phase of the study for approximately 30 minutes to review the sleep and
behavior diaries and exchange actigraphs. Once baseline data were determined stable, or
14 consecutive days of data was collected, the treatment phase was introduced, and
parents were taught to implement the BFRC protocol. Parents were instructed in the
implementation of a modified BFRC protocol (i.e., bedtime procedures, response cost,
and bedtime fading) and received an outline of procedures (see Appendix E).
Bedtime fading instructions included:
(i) Adjust bedtime for the following night according to child’s previous time of
sleep onset by 15 minutes. For example, if child’s initial bedtime was 10:30
p.m., and he/she fell asleep within 15 minutes of being placed in bed, fade the
bedtime to 10:15 p.m.; and
(ii) If child did not fall asleep within 15 minutes of the initial bedtime, push back
the bedtime to 10:45 p.m.
Bedtime procedures included:
(i) Follow regular bedtime routine and place child in his/her bed at the initial
adjusted bedtime;
(ii) After 15 minutes, check to see if child is awake by standing within one foot of
the bed and whispering his/her name. If there are no observable motor or
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verbal responses (i.e., opening eyes, talking, etc.) it is safe to assume child is
asleep; and
(iii) If determined that child is awake (i.e., he/she responded to whisper),
implement response cost.
Response cost procedures included:
(i) Remove child from the bed and bedroom and allow him/her to partake in
activities not related to sleep for 30 minutes, such as playing with toys or
watching TV; and
(ii) At the end of 30 minutes, return child to his/her bed;
(iii) Repeat the procedure if your child does not fall asleep within 15 minutes of
being returned to bed; and
(iv) Address nighttime awakenings by returning child to his/her bed with minimal
parental attention and interaction.
Parents received feedback from a trained clinician as they verbally described how
to implement BFRC with their child. Once parent dyads correctly reported how to
implement each component of BFRC, they were provided blank diaries and an actigraph
to begin treatment phase data collection. Finally, each parent completed the KMSS
independently, once weekly for the duration of the study.
Treatment
A member of the investigative team assisted parents in determining parentpreferred bedtime goals. A consistent wake time and naptime (if applicable) were derived
using developmental norms (Iglowstein, Jenni, Molinari, & Largo, 2003) and parent sleep
goals. Baseline data were used to determine the initial bedtime by calculating the average
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sleep onset time and adding 30 minutes. Parents were asked to enforce a consistent wake
time every morning regardless of their child’s sleep behaviors the night before. Parents
were also asked to eliminate access to non-established daytime sleep, such as naps, unless
appropriate for the age and developmental needs of their child. Parents were required to
regulate the timing and duration for any established naps, regardless of the amount or
quality of sleep the child had the night before, and to not permit access to sleep outside of
the designated times. If the child eloped from the bedroom, parents were asked to return
him or her to bed and ignore all disruptive behaviors as long as they were not harmful to
the child or others.
Parents were taught a modified BFRC protocol and received an outline of the
following procedures: (a) Bedtime protocol: (i) Follow the regular bedtime routine and
place child in his/her bed at the initial adjusted bedtime. (ii) After 15 minutes, check to
see if child is awake by standing within one foot of the bed and whispering his/her name.
If there are no observable motor or verbal responses (i.e., opening eyes, talking, etc.), it is
safe to assume the child is asleep. (iii) If the child is awake (i.e., he/she responded to your
whisper), implement response cost. (b) Response cost: (i) Remove child from the bed and
bedroom and allow him/her to partake in activities not related to sleep for 30 minutes,
such as playing with toys or watching TV. (ii) At the end of 30 minutes, return child to
his/her bed. (c) Repeat the procedure if child does not fall asleep within 15 minutes of
being returned to bed. (d) Address nighttime awakenings by returning child to his/her bed
with minimal parental attention and interaction. (e) Bedtime fading: (i) Adjust the
bedtime for the following night according to child’s previous time of sleep onset by 15
minutes. For example, if child’s initial bedtime was 10:30 p.m., and he/she fell asleep
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within 15 minutes of being placed in bed, fade the bedtime earlier by 15 minutes to 10:15
p.m.. If the child did not fall asleep within 15 minutes of the initial bedtime, push the
bedtime later by 15 minutes to 10:45 p.m.
After being trained to implement the BFRC protocol, parents continued to meet
with a member of the investigative team once a week for approximately 30 minutes to
review sleep and behavior diaries and exchange actigraphs. During the treatment phase, a
researcher contacted the designated parent responsible for data collection by telephone
approximately every other day to check on “data collection efforts” (Durand & Mindell,
1999). Parents answered a series of questions related to the BFRC procedures and data
collected. Information provided was recorded in a modified diary and compared with
parent completed sleep and behavior diaries at the end of the study. Parents were asked to
complete the CSHQ-A at the end of the treatment phase.
Follow-up
Approximately four weeks after the end of treatment, parents met with a member
of the investigative team for approximately 30 minutes to receive data sheets and an
actigraph. Parents collected sleep and behavior data for a minimum of 4 and maximum of
7 consecutive days. At the end of the follow-up data collection phase, parents attended a
closing session to complete the CSHQ-A and PCSQ and return data and the actigraph.
Parents attended between five and eight sessions to complete the study, depending on
outcomes (see Table 3). For example, if a stable trend in the baseline and treatment data
was observed, then sessions two, three, four, and five were consolidated into two
sessions.
Research Design
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A non-concurrent multiple baseline design across participants was used (Harvey,
May, & Kennedy, 2004; Watson & Workman, 1981). Baseline lengths were staggered
across participants and information was collected until data stability and trend were
observed or for a maximum of 14 days if stability was not observed, followed by a
maximum of 14 days for the treatment phase. It was expected that changes may occur in
each participant’s sleep behavior under the treatment condition, while participant’s sleep
behavior during baseline may remain unchanged. Follow-up measures were collected one
month following the conclusion of treatment, for a maximum duration of one week.
Visual inspection of baseline data was utilized to assess stability and trends in the data
and determine the introduction of the treatment phase for each individual participant
(Harvey, May, & Kennedy, 2004; Watson & Workman, 1981). For example, once the
frequency of Bill’s undesired co-sleeping was stable and the trend was not decreasing
(after 6 days), the treatment phase was initiated. Similarly, when the frequency of Keith’s
undesired co-sleeping was not stable or the trend was decreasing, treatment was delayed
until baseline data demonstrated a stable trend in the desired direction (or for a total of 14
days). This time-lagged approach demonstrates experimental control through the
sequential introduction of treatment once stable baseline levels in the dependent variables
were observed (Harvey, May, & Kennedy, 2004).
Data analysis
Means and standard deviations were calculated for WASO, SOL, TST, and SE
from data recorded by actigraphy and in sleep diaries (Moon, Corkum, & Smith, 2010).
Mean frequencies and standard deviations for FNA, DSO, and non-designated sleep were
calculated from data recorded in the sleep and behavior diary. Means and standard
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deviations for undesired co-sleeping were also calculated using data recorded in behavior
and sleep diaries (Weiskop, Matthews, & Richdale, 2001). Raw scores on the CSHQ-A
subscales of bedtime resistance, sleep onset delay, sleep duration, sleep anxiety, night
awakenings, parasomnias, sleep disordered breathing, and daytime sleepiness were
reported (see table; Moon, Corkum, & Smith, 2010). Daily means for the frequency and
duration of disruptive behaviors were calculated using data from the sleep and behavior
diaries (Weiskop, Richdale, & Matthews, 2005). Level of success of parents’ treatment
sleep goals was calculated using the GAS at the end of baseline, intervention, and followup conditions and expressed as % (Weiskop, Matthews, & Richdale, 2001; Weiskop,
Richdale, & Matthews, 2005). Mean level of satisfaction (%) was also calculated from
KMSS raw scores for each parent during all three phases.
Results
Data from each child were analyzed individually because a non-concurrent
multiple baseline design across participants was used in this study. Changes in trends and
patterns for the primary dependent variables are provided below. Each of the three
parents dyads generated sleep-related goals for their own child and worked with a
member of the investigative team to refine and determine the levels of success for each
goal (see Table 4).
Undesired co-sleeping
Undesired co-sleeping was the only sleep problem consistently reported by the
parents of all three participants. Parents generated a goal using the GAS to reduce
undesired co-sleeping in the parent’s bed (see GAS section for details). Frequency and
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duration of undesired co-sleeping with parents reduced after the onset of BFRC for all
three children as measured by the sleep-related behavior diaries (see Figures 1 and 2). For
Holly, undesired co-sleeping occurred once per night during baseline, averaging 653
minutes per night. This decreased to 0 minutes during treatment and was maintained at
that level at follow-up. Bill’s frequency of undesired co-sleeping was once per night
throughout baseline, with a mean duration of 230 minutes per night, which also decreased
to 0 minutes during treatment and was maintained at that level at follow-up. It should be
noted that on the third night of treatment, Bill’s parent chose to co-sleep with him in the
child’s bed for 90 minutes after an instance of bedwetting. This occasion did not meet the
definition of undesired co-sleeping; therefore, the frequency and duration were not
included in the final data set. Alternatively, had this one-time occurrence been included,
undesired co-sleeping decreased from baseline to 0.1 occurrences and an average of 6
minutes per night at the end of treatment. Keith demonstrated a dramatic decrease from
the mean frequency of 2 occurrences per night (mean duration of 57 minutes per
occurrence) during baseline to 0.1 occurrences and an average of 1 minute per night
during treatment. One episode of undesired co-sleeping occurred on the last night of the
treatment phase in the parents’ bed for 15 minutes. Undesired co-sleeping for Keith
slightly increased to 0.3 occurrences, with a mean duration of 9 minutes per night,
throughout follow-up. These instances occurred on separate days in the parent’s bed,
lasting less than 45 and 15 minutes each.
Non-designated sleep
Frequency and location of sleeping in a non-designated area were reported for Bill
and Keith, whereas Holly maintained zero occurrences during all three phases of the
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study. Both Bill and Keith showed reduction in the frequency of sleeping in a nondesignated area. For Bill, mean frequencies of sleep in a non-designated area (location
not reported) decreased from 0.16 occurrences during baseline to zero occurrences
throughout treatment. For Keith, mean frequencies of sleep in a non-designated area
decreased by half from baseline (0.13) (located in the car and on the couch) to treatment
(0.06) (located in the car). This single episode of sleeping in a non-designated area
occurred during a change in routine. Keith’s parents reported they had traveled by car out
of town for the day, and the return trip coincided with Keith’s bedtime, at which time he
fell asleep and remained asleep for the duration of the car ride (2.5 hours). Follow-up
data demonstrated a total elimination of sleeping in a non-designated area for Bill and
Keith.
Bedtime resistance
Bedtime resistance (BR) was a reported concern for Bill’s parents only, although
all three children engaged in disruptive behaviors during the bedtime routine and after
being placed in bed, as recorded in the sleep-related behavior diaries (see Figure 3). For
Holly, mean duration of BR per night decreased from 15 minutes during baseline to 0.4
minutes at the end of treatment and further decreased to 0.3 minutes during follow-up.
Night-by-night inspection of Holly’s sleep-related behavior diary indicated a one-time
change in her bedtime routine (i.e., attending a party for 30 minutes past bedtime), which
may have contributed to the duration of BR during follow-up. Both Keith and Bill
experienced extinction bursts (increase in mean duration of BR) during the treatment
phase, with a sharp decrease beyond baseline levels during follow-up. Bill’s mean
duration of BR per night greatly increased from baseline (12.4 minutes per night) to
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treatment (55 minutes per night) and then significantly decreased throughout follow-up (4
minutes per night). For Keith, BR mean duration per night increased from baseline (1.3
minutes per night) to treatment (6.3 minutes per night), and decreased to near 0 minutes
during follow-up (0.1 minutes per night). Overall, Keith’s BR duration increased by only
an average of 5 minutes during treatment and reduced by 6.2 minutes at follow-up.
Parents in this study reported no occurrences of aggressive behavior when
returning the child to their own bed following elopement. Night-by-night sleep-related
behavior diary for Bill indicated a spike in BR duration by 150 minutes the same day he
experienced a significant deviation in routine (i.e., attended only ½ day of school and no
swim class), which was preceded and succeeded by nights with BR rates of zero. Bill’s
parents noted this change in schedule might have greatly contributed to his resistance to
bedtime. Bill’s CSHQ-A bedtime resistance subscale scores decreased from baseline (9)
to treatment (6) and were maintained during follow-up (6). Likewise, Keith’s CSHQ-A
bedtime resistance subscale scores decreased from baseline (12) to treatment (7) and were
maintained during follow-up (6). Holly’s CSHQ-A bedtime resistance baseline subscale
score of 14 decreased to 6 during follow-up.
Disruptive behavior composite
Mean scores of Disruptive Behavior Composite (DBC) were extrapolated from
the sleep-related behavior diaries and patterns similarly to the mean durations and
frequencies of BR for all three children (see Figure 4). Holly’s DBC mean scores
decreased slightly from the baseline (1.3 per night) to the end of treatment (1.2 per night)
and displayed a downward trend. Her DBC further decreased during follow-up (0.5 per
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night). Night-by-night inspection indicated that disruptive behaviors during her bedtime
routine or after she was placed in her bed for the night were eliminated, and only the
number of times she escaped from her bedroom after being put in bed for the night
contributed to her DBC mean scores. Holly’s nightly DBC scores varied throughout
treatment with a subtle downward trend that remained below baseline at the end of
follow-up. A change in Holly’s routine may have contributed to one of two instance of
BR during follow-up, thus increasing her DBC. Bill’s DBC increased slightly from
baseline (5.3 per night) to treatment (5.7 per night).
Similarly to Holly’s, Bill’s night-by-night data indicated that disruptive behaviors
during his bedtime routine decreased to almost none. Furthermore, Bill’s disruptive
behaviors occurring after he was placed in his bed for the night decreased, while the
number of times he came out of his bedroom after being placed in bed for the night
increased during treatment. Visual analysis of the plotted data showed an unexpected
uptick in the frequency of BR on the same day Bill experienced a significant deviation
from his daily routine. Such deviation may have negatively impacted his DBC. His DBC
decreased throughout follow-up to 2 per night. As for Keith, his DBC doubled from
baseline (1.1 per night) at the end of treatment (2.2 per night) and decreased to near 0
minutes during follow-up (0.1 per night) with no clinically relevant differences across
topography.
Night awakenings
Frequent night awakenings (FNA) were a parent-reported sleep problem for Bill
and Keith. Both children showed some decrease in the number of night awakenings
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during the implementation of BFRC as measured by sleep diaries (see Figure 5). Bill’s
FNA slightly decreased from 1.2 occurrences per night at baseline to an average of 1 per
night throughout treatment, whereas Keith’s FNA per night decreased from 0.6 per night
at baseline to 0.3 per night during treatment. Night-by-night sleep diary data for Bill
indicated a progressive decrease in FNA during treatment with four consecutive nights of
zero night awakenings nearing the end of treatment with an increase in FNA the
following night. Bill used the bathroom independently once that night, which accounts
for one FNA. Bill’s parents indicated a deviation from his typical daytime routine
resulting in a lack of exercise, which might have had a negative impact on his sleep and
contributed to the unexpected increase of FNA. Additionally, at least one night
awakening on each of the first, third, and fourth nights of the treatment phase were the
result of bedwetting and required parental assistance in changing bedding and pajamas.
These instances were not recorded as FNAs. Follow-up data demonstrated a total
elimination of FNA for Bill and Keith.
Holly experienced an increase and fluctuation in the frequency of night
awakenings from baseline (0 per night) to a mean frequency of 0.7 per night during
treatment, which returned to near baseline levels during follow-up (0.5 per night). Prior to
BFRC, Holly slept through the night in her parents’ bed with at least one parent in the
room at all times. This standard might have been greatly reducing the likelihood of FNA.
Therefore, the adjustment to sleeping alone in her own bed may have produced FNA
during treatment. Visual analysis of the data showed FNA decreased to zero the last night
of treatment, maintained the first three nights of follow-up, and increased by 2 instances
the final night of follow-up due to a change in routine (i.e., party attendance and delayed
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bedtime). Bill’s CSHQ-A night wakings subscale scores decreased from baseline (7) to
treatment (6), and further decreased during follow-up (4), whereas Holly’s CSHQ-A
bedtime resistance subscale score remained stable from baseline (5) throughout followup. Keith’s CSHQ-A night wakings subscale scores decreased from baseline (7) to
treatment (4) and then slightly increased during follow-up (5).
Dependent sleep onset
Dependent sleep onset (DSO) was a parent-reported problem for Holly and Keith
as both children required a parent in the room to fall asleep. DSO, as measured by the
sleep diaries, was eliminated for all three children (see Figure 6). Holly’s DSO occurred
steadily once per night during baseline, whereas Keith’s baseline DSO varied between 1
and 3 times per night with a mean frequency of 1.7 per night. Bill’s baseline DSO
generally occurred once a night with a mean frequency of 1.2 occurrences per night. Each
child’s DSO decreased to zero after the onset of BFRC and remained at the 0-per-night
level at follow-up.
Sleep onset latency
Night-by-night inspection of mean sleep onset latency (SOL), as measured by
sleep diaries, revealed an overall reduction in SOL at during follow-up for Bill and Keith,
whereas Holly’s mean SOL increased above baseline (see Table 5). Bill’s baseline mean
SOL (57.5 minutes) decreased by over 50% by end of treatment (25.7 minutes), and
again at follow-up (11.3 minutes). This clinically meaningful improvement highlights the
effectiveness of BFRC in the reduction of SOL for a child with ASD that experienced
significant sleep onset delays. Visual analysis of Bill’s night-by-night sleep diary data
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showed an increase in SOL the same day he experienced a change in routine, suggesting
a more consistent schedule may have resulted in greater improvement of SOL. Keith’s
mean SOL baseline (9.6 minutes) – already an acceptable level of latency – greatly
increased during treatment (33.2 minutes). This abrupt increase in SOL occurred the first
night of treatment; SOL progressively decreased and remained at a lower level during
follow-up (4.3 minutes).
Mean SOL recorded by actigraphy decreased from baseline to the end of
treatment for Holly and Bill (see Table 5). Actigraphy treatment phase data for Keith
were lost due to a software malfunction. Actigraphy data on Holly’s mean SOL indicated
a decrease of 29.7 minutes from baseline (43.5 minutes) to treatment (13.8 minutes) with
a return toward baseline levels (32 minutes) at the end of follow-up. Bill’s mean SOL
decreased by 50 minutes from baseline (74 minutes) to treatment (24 minutes) and
increased by 7.3 minutes at follow-up (31 minutes). Keith’s remaining actigraphy data
indicated his mean SOL decreased from baseline (13 minutes) to follow-up (5.6 minutes)
by 7.4 minutes. Bill’s CSHQ-A sleep onset delay subscale scores decreased from baseline
(3 minutes) to treatment (1 minute) and were maintained during follow-up (1 minute).
Holly and Keith’s CSHQ-A sleep onset delay subscale scores of 1 were maintained
throughout the study.
Waking after sleep onset
Mean values of night awakenings after sleep onset (WASO) in minutes, as
measured by sleep diaries, revealed a progressive reduction in night-awakenings after
sleep onset for Keith, whereas Holly’s and Bill’s mean WASO increased from baseline
levels at the end of treatment (see Table 5). Keith’s WASO in minutes decreased from 16
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minutes at baseline to 6.4 minutes during treatment and to zero during follow-up. Holly’s
WASO increased from 0 minutes at baseline to 29 minutes at the end of treatment,
followed by a decrease to 11.3 minutes during follow-up. Visual analysis of the data
showed WASO maintained duration of 0 minutes on the first three out of four nights of
follow-up and increased by 45 minutes on the final night. This increase corresponds with
the uptick of FNA on the same night and may also be contributed to a change in Holly’s
bedtime. Bill’s WASO increased by 6 minutes from baseline (35 minutes) to treatment
(41 minutes) and decreased to 0 minutes at follow-up. Akin to his FNA sleep diary data,
Bill’s night-by-night data showed a progressive decrease in mean WASO during
treatment. Specifically, Bill experienced four consecutive nights of 0 minutes awake after
sleep onset toward the end of treatment. The following night, WASO increased by 180
minutes (3 hours), which may have resulted from the unexpected change in his daytime
routine and activity level.
WASO recorded by actigraphy decreased from baseline to the end of treatment
for Holly and Bill (see Table 5). As previously reported, actigraphy treatment phase data
for Keith were lost due to a software malfunction. Holly’s mean WASO decreased by
101 minutes from baseline (192 minutes; 3.2 hours) to treatment (91.3 minutes; 1.5
hours), with a return toward baseline levels (132.5 minutes; 2.2 hours) at the end of
follow-up. Bill’s mean WASO decreased by 55 minutes from baseline (105 minutes; 1.8
hours) to treatment (50 minutes), and the decrease was maintained at follow-up. Keith’s
remaining actigraphy data indicated his mean WASO increased slightly from baseline (51
minutes) to follow-up (57 minutes).
Time in bed
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Time in bed (TIB) means measured in minutes by sleep diaries revealed an
overall reduction in time spent in bed from baseline through follow-up for all three
children. This calculation included the total amount of time the child was physically in
bed during a 24-hour period. Holly and Keith’s TIB progressively reduced throughout the
study, whereas Bill’s TIB slightly increased during follow-up (see Table 5). Bill’s mean
TIB decreased by 1 hour and 14 minutes from baseline (595 minutes; 9.9 hours) to
treatment (521 minutes; 8.7 hours). His mean TIB slightly increased – by 27 minutes –
from treatment to follow-up (548 minutes; 9.1 hours). Holly’s mean TIB baseline (671
minutes; 11.2 hours) decreased by 45 minutes at the end of treatment (626 minutes; 10.4
hours), followed by an additional decrease of 11 minutes during follow-up (615 minutes;
10.3 hours). Keith’s mean TIB decreased from baseline (638 minutes; 10.6 hours) by 13
minutes at the end of treatment (625 minutes; 10.4 hours), and another 12 minutes at the
end of follow-up (613 minutes; 10.2 hours). Overall, TIB means reduced from baseline to
follow-up by 56 minutes for Holly, 47 minutes for Bill, and 25 minutes for Keith.
Correspondingly, TIB recorded by actigraphy decreased for all three children (see
Table 5). Holly’s mean TIB decreased by approximately 1 hour from baseline (667
minutes; 11.1 hours) to treatment (605 minutes; 10.1 hours) and increased by 37 minutes
from treatment to the end of follow-up (642 minutes; 10.7 hours). Similarly, Bill’s mean
TIB decreased by 1 hour and 41 minutes from baseline (609 minutes; 10.2 hours) to
treatment (508 minutes; 8.5 hours) and increased by 41 minutes throughout follow-up
(549 minutes; 9.2 hours). Holly experienced an overall reduction in TIB of 25 minutes
(31 minutes less than recorded in sleep diaries), whereas Bill’s TIB reduced by 1 hour (13
minutes more than recorded in sleep diaries). Much the same, Keith’s mean TIB
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decreased from baseline (598 minutes; 10 hours) to follow-up (567 minutes; 9.5 hours)
by 31 minutes (6 minutes more than recorded in sleep diaries).
Total sleep time
Total sleep time (TST) means measured by sleep diaries decreased from baseline
to the end of treatment for all three children (see Table 5). TST was calculated by adding
the durations of daytime and nighttime sleep within a 24-hour period. None of the parent
dyads scheduled naptimes for their child; therefore a majority of sleep took place during
the night. Holly’s baseline mean TST (653 minutes; 10.9 hours) decreased by the end of
treatment (551 minutes; 9.2 hours) by 1 hour and 42 minutes and then increased by 27
minutes during follow-up (578 minutes; 9.6 hours). Her average decrease in mean TST
was 1 hour and 15 minutes. Bill’s baseline mean TST (503 minutes; 8.4 hours) decreased
by 57 minutes by the end of treatment (446 minutes; 7.4 hours) and reverted above
baseline levels by 30 minutes (533 minutes; 8.9 hours) during follow-up.
Although none of the parents were interested in adding naps to their child’s sleep
routine, Keith’s parents reported he had been allowed to nap during the day occasionally
due to not sleeping either most or all of the night. This decreased the likelihood of him
successfully sleeping through the night. Keith took two naps throughout the entire study,
each on separate days during baseline. The first nap (15 minutes, 11:45 a.m.to 12:00
p.m.) occurred after sleeping for only 8.25 hours the night before with a terminal wake
time of 2:00 a.m. Two days later, the second nap (3.75 hours, 8:15 a.m.to 12:30 p.m.)
occurred after sleeping only 4.5 hours the night before with a terminal wake time of
11:00 p.m. Naps were eliminated for Keith at the onset of BFRC; this practice was
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maintained through follow-up. Both naps included, Keith’s mean baseline TST (599
minutes; 10 hours) decreased by 20 minutes by the end of treatment (579 minutes; 9.7
hours). His TST also reverted above baseline levels by 10 minutes (609 minutes; 10.2
hours) during follow-up.
Mean TST recorded by actigraphy increased for Holly and Bill and decreased for
Keith from baseline to follow-up (see Table 5). Holly’s mean TST actigraphy data
increased by 1 hour and 32 minutes from baseline (399 minutes) to treatment (491) and
decreased by 16 minutes by the end of follow-up (475). Her overall TST increased by 1
hour and 16 minutes. Bill’s mean TST decreased by 13 minutes from baseline (415) to
treatment (402) and increased by 1 hour and 2 minutes by the end of follow-up (464). His
overall TST increased by 49 minutes. Keith’s mean TST decreased from baseline (525) to
follow-up (502) by 23 minutes. Bill’s CSHQ-A sleep duration subscale scores did not
change from baseline (5) to treatment (5) and decreased during follow-up (3), whereas
Holly’s CSHQ-A sleep duration subscale scores did not change from baseline (3) through
follow-up. Keith’s CSHQ-A sleep duration subscale scores decreased from baseline (6) to
treatment (3) and did not change during follow-up (3).
Sleep efficiency
Sleep efficiency (SE) outcomes extrapolated from sleep diaries data indicate all
three children overall maintained or improved the percentage of their sleep efficiency.
Holly’s baseline SE of 97% decreased to 88% at the end of treatment and increased to
94% during follow-up. Bill’s baseline SE increased slightly from 85% to 86% at the end
of treatment, and further increased to 97% during follow-up. Keith’s baseline SE of 94%
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decreased slightly to 92% at the end of treatment and increased to 99% throughout
follow-up. Compared with these data, SE outcomes extrapolated from actigraphy data
were lower for each child. For example, Holly’s baseline SE of 60% increased to 82% at
the end of treatment, and decreased to 75% during follow-up. Bill’s baseline SE
increased from 68% to 80% at the end of treatment, and further increased to 85% during
follow-up. Keith’s baseline SE of 89% was maintained during follow-up.
Children’s Sleep Habits Questionnaire, Abbreviated Version
BFRC led to a significant reduction in the Children’s Sleep Habits Questionnaire,
Abbreviated Version (CSHQ-A) total sleep disturbance scores for all three children. Total
sleep disturbance scores drastically decreased from the clinical range during baseline to
the non-clinical range by follow-up for two children, whereas the third child’s follow-up
score was only 1 point above the proposed clinical cutoff score (41). Specifically, Bill’s
baseline CSHQ-A total score of 48 decreased to 43 at the end of treatment, and further
decreased to 36 during follow-up, with an overall decrease of 12 points. Keith’s total
baseline score of 60 significantly decreased to 46 at the end of treatment, with an
additional decrease to 42 during follow-up, with a decrease of 18 points, which represents
the the greatest improvement among the study participants. Likewise, Holly’s CSHQ-A
total score at baseline (56) decreased by the end of follow-up (40), leaving her with the
second best reduction in score of 16 points.
As previously mentioned, Holly’s CSHQ-A subscale scores for sleep onset delay
(1), sleep duration (3), and night wakings (5) remained unchanged from baseline
throughout follow-up (EOT data not available), whereas bedtime resistance significantly
decreased from 14 to the minimum score of 6 (see Table 5). Similarly, Keith’s CSHQ-A
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subscale score for sleep onset delay remained unchanged throughout the study at a
baseline score of 1. In contrast to Holly’s score, Keith’s CSHQ-A subscale score for sleep
duration decreased from baseline (6) by half at the end of treatment (3) and remained
unchanged during follow-up. His CSHQ-A subscale score for night wakings also
decreased from baseline (7) to treatment (4) but then slight increased at follow-up (5).
Keith’s CSHQ subscale score for bedtime resistance decreased from baseline (12) to the
end of treatment (7), with an additional decrease at follow-up (6).
Bill’s CSHQ-A subscale score for sleep onset delay decreased from baseline (3)
to the minimum score at the end of treatment (1) and did not change during follow-up.
His CSHQ-A subscale score for bedtime resistance followed a similar pattern with a
decrease from baseline (9) to the minimum score at the end of treatment (6), which did
not change during follow-up. Bill’s CSHQ-A sleep duration subscale score maintained at
baseline through end of treatment (5) and decreased to the minimum score (3) at the end
of follow-up, whereas night wakings slightly decreased from baseline (7) to end of
treatment (6), with a near minimal level decrease during follow-up (4). CSHQ-A sleep
disordered breathing scores were reported within 1 point (range 3 to 4) of the minimal
level (3) and determined non-clinically significant for all three children.
Goal Achievement Scale
Parents set sleep-related goals for their child and worked with a member of the
investigative team to refine and determine the levels of success for each goal (see Table
4). Keith had four goals, whereas Holly and Bill had two goals each. The only similar
parent-set goal across all three children was to reduce undesired co-sleeping in the
parent’s bed by having the child sleep alone in their own bed. The percentage of nights
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during the treatment phase when each child slept in their own bed dramatically increased
for all three children as measured by the sleep-related behavior diaries. Bill’s goal of
sleep through the night in [his] own bed dramatically increased from 0% success (0 out
of 6 nights) during baseline, to 100% success (14 out of 14 nights) at the end of treatment
phase, which remained at 100% success (4 out of 4 nights) through follow-up.
Similarly, Holly’s goal of sleep in [her] own bed (every night) increased from 0%
success (0 out of 4 nights) during baseline to 100% success (11 out of 11 nights) at the
end of the treatment phase and remained at 100% success during follow-up (4 out of 4
nights). Keith’s goal of falling asleep on own (in [his] own bed) increased from 0%
success (0 out of 14 nights) during baseline to 100% success (14 out of 14 nights) at the
end of the treatment phase and remained at 100% success (7 out of 7 nights) during
follow-up. Keith’s goal of sleeping through the night in [his] own bed (return to sleep
during the night by himself) went from 0% success (0 out of 14 nights) during baseline to
93% success (13 out of 14 nights) at the end of treatment. This goal’s success decreased
to 75% (5 out of 7 nights) during follow-up due to briefly engaging in undesired cosleeping in the parent’s bed (mean of 9 minutes) on two separate nights.
Bill’s and Keith’s parents had different goals related to the time their child went
to sleep each night. Bill’s parents’ goal to go to sleep sooner (reduce SOL each night)
was set at equal to or less than 15 minutes in order to achieve 100% success. He
improved from 0% success (average of 57.5 minutes per night) during baseline to 75%
success (average of 25.7 minutes per night) at the end of the treatment phase, which
further increased to 100% success (average of 11.3 minutes per night) during follow-up.
Keith’s parents’ goal of bedtime between 7:00 and 7:30 p.m. was set to 7 out of 7 nights
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to achieve 100% success. This goal increased from 1% success (1 out of 14 nights)
during baseline to 43% success (6 out of 14 nights) at the end of the treatment phase, and
further increased to 86% success (6 out of 7 nights) during follow-up, thus indicating
BFRC provided the structure necessary to achieve success.
Holly’s and Keith’s parents had similar goals for the amount of sleep their child
received each night. Members of the investigative team used sleep norms (Iglowstein, et
al., 2003) to help parents set the goals. Norms for total sleep duration per 24-hour period
range between 9.6 and 11 hours for children ages 8 and 9 years and between 10.5 and
12.8 hours for children ages 4 to 5 years (Iglowstein, et al., 2003). Based on these norms,
Holly’s goal to get required amount of sleep for [her] age (every night) decreased from
50% success (2 out of 4 nights) during baseline to 18% success (2 out of 11 nights) at the
end of the treatment phase, followed by a return to baseline level 50% (2 out of 4 nights)
during follow-up. Keith’s goal to get enough sleep (developmentally appropriate amount
per night) also decreased from baseline 36% success (5 out of 14 nights) to 21% success
(3 out of 14 nights) at the end of the treatment phase and increased to 43% success (3 out
of 7 nights) during follow-up.
In contrast to the recommendations published by Iglowstein and colleagues
(Iglowstein, et al., 2003), the National Sleep Foundation recommendations on sleep
duration per 24 hours are between 10 to 13 hours of sleep for children ages 3 to 5 years
and between 9 and 11 hours for children ages 6 to 13 years (Hirshkowitz, et al., 2015).
Even though these recommendations were not available at the beginning of our study,
these norms were compared with Holly’s and Keith’s total sleep time (TST) values. The
results of this comparison revealed a steady improvement in sleep duration goals for both
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children. Holly’s baseline level of 50% success (2 out of 4 nights) increased to 64%
success (7 out of 11 nights) at the end of the treatment phase, and further increased to
100% success (4 out of 4 nights) during follow-up, whereas Keith’s baseline level of 57%
success (8 out of 14 nights) remained stable through the end of the treatment phase and
further increased to 71% success (5 out of 7 nights) during follow-up.
Although sleep duration norms for children with ASD have yet to be established,
Hodge and colleagues (Hodge, Carollo, Lewin, Hoffman, & Sweeney, 2014) found that
children with ASD between ages 3 and 17 years experienced significantly less overall
sleep (mean, 8 hours and 47 minutes; standard deviation, 93 minutes) compared with
typically developing peers (mean, 9 hours and 22 minutes; standard deviation, 76
minutes). Compared with these findings, Holly’s baseline level of 25% success (1 out of
4 nights) increased to 82% success (9 out of 11 nights) at the end of the treatment phase,
and further increased to 100% success (4 out of 4 nights) during follow-up, whereas
Keith’s baseline level of 50% success (7 out of 14 nights) increased to 64% success (9
out of 14 nights) at the end of the treatment phase and decreased to 29% success (2 out of
7 nights) during follow-up (Hodge, Carollo, Lewin, Hoffman, & Sweeney, 2014).
Kansas Marital Satisfaction Scale
Parent-completed Kansas Marital Satisfaction Scale (KMSS) indicated a possible
ceiling effect for two of the three parent dyads (see Table 6). Bill’s and Keith’s parents
each reported being extremely satisfied (7) on all three KMSS probes (i.e., 1) How
satisfied are you with your marriage?; 2) How satisfied are you with your husband/wife
as a spouse?; and 3) How satisfied are you with your relationship with your
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husband/wife?) at baseline, end of treatment, and follow-up. Therefore, Bill’s and Keith’s
parents’ total individual KMSS scores were maintained at the ceiling level of 21 for each
parent throughout the study, thus staying above the cut-off score of 17 for distressed
couples. In contrast, Holly’s parents each endorsed being somewhat satisfied (5) with
their marriage and very satisfied (6) with their husband or wife as a spouse and with their
relationship with their husband or wife at baseline and end of treatment. Holly’s parents’
KMSS scores with regard to their marriage increased by 1 point each from somewhat
satisfied to very satisfied (6), while the other scores remained unchanged through to
follow-up. Total individual KMSS scores for Holly’s parents remained stable from
baseline (17) through end of treatment and increased at follow-up (18), also staying
above the cut-off score indicating marital distress.
Parent’s Customer Satisfaction Questionnaire
Parent’s Customer Satisfaction Questionnaire (PCSQ) mean-ratings indicate high
levels of satisfaction with treatment implementation and outcomes across all three
families. Holly’, Bill’s, and Keith’s parents endorsed that the major problems that
originally prompted treatment and the problems treated during this study had greatly
improved (mean rating of 7). All three parent dyads endorsed feeling very positive (mean
rating of 7) about the treatment program, feeling very satisfied (mean rating of 7) about
their child’s progress, and would strongly recommend (mean rating of 7) the treatment
program to a friend or relative. Parental expectations for a satisfactory outcome of the
treatment at the end of follow-up were optimistic (Keith) or very optimistic (Holly and
Bill; mean rating of 6.66).
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Each parent endorsed being very confident (mean rating of 7) in their ability to
manage future in-home sleep problems based on what they learned during the study,
whereas only Holly’s and Bill’s parents also endorsed being very confident (7) in their
ability to manage current in-home sleep problems independently, resulting in an overall
mean ratings of 5. This discrepancy in endorsements by Keith’s parents may due to the
reverse selection of the response options for this particular question, suggesting a rating
of 7 may have been intended as opposed to 1 (i.e., 1 = Very unconfident verses 7 = Very
confident). Problems related to the children not treated during the study have either
remained the same (Holly and Keith) or slightly improved (Bill; mean rating 4.33),
whereas the degree to which the treatment program helped parents with other personal or
family problems have either helped (Holly and Keith) or helped slightly (Bill; mean
rating 5.66).
In the open-ended questions, parents were invited to share their opinions on the
best and worst components of the treatment program. The most helpful components
included ‘sleeping in parents’ bed stopped completely’ for Bill; ‘getting her to sleep in
her own bed’ for Holly; and ‘creating strict bedtime rules and sticking to it’ for Keith.
Parents reported liking most the ‘results; treatment solved problems’ (Bill); ‘easy to
follow/implement’ (Holly); and ‘having us have rules to establish a better bedtime
routine’ (Keith). Bill and Keith’s parents liked least the ‘lack of sleep a few nights’ (Bill)
and ‘first few days were difficult, but it got better. those days were tough! and data
entry.’ (Keith). Holly’s parents indicated that there was nothing they liked least about the
treatment program, whereas each parent dyad endorsed none of the treatment program
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components as least helpful. Likewise, none of the parents reported any part of the
treatment program as not helpful, nor did they offer recommendations for improvement.
Discussion
The results of this study add to the literature supporting BFRC as an effective
treatment option for co-occurring sleep problems experienced by children with ASD.
This study evaluated the effectiveness of BFRC as an in-home treatment with parents as
change agents in decreasing parent-defined sleep disturbances, such as undesired cosleeping, night awakenings, difficulty falling asleep, and bedtime disturbances
experienced by children with ASD. While this study centered on improving the sleep of
children diagnosed with ASD by means of BFRC, innovative concepts of the study were
to utilize parents to determine and implement treatment according to parent-derived sleep
goals for their children.
Previous BFRC research on sleep disturbances in children with ASD (DeLeon,
Fisher, & Marhefka, 2004; Moon, Corkum, & Smith, 2010; Piazza, Fisher, & Sherer,
1997) had not considered such novel aspects simultaneously. For example, two studies
(DeLeon, Fisher, & Marhefka, 2004; Piazza, Fisher, & Sherer, 1997) were restricted to
institutionalized settings with BFRC implemented by trained professionals, one study
(Moon, Corkum, & Smith, 2010) involved training parents to implement BFRC in the
home setting, and one study (Piazza, Fisher, & Sherer, 1997) used sleep norms in
conjunction with parent goals to establish ideal sleep and wake times for their child. The
current study extends both the science and practice of increasing parental agency while
providing BFRC as a treatment option for children with ASD and co-occurring sleep
disturbances.
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The primary sleep problem across all three families – frequency and duration of
undesired co-sleeping – improved for each child. Visual analysis showed improvement in
baseline levels immediately following treatment onset. These improvements were
maintained at one-month follow-up; thus, BFRC was effective in reducing (Keith) and
eliminating (Holly and Bill) the frequency and duration of undesired co-sleeping. Neither
frequency nor duration of undesired co-sleeping was negatively impacted by changes in
routine for any of the children. Furthermore, parent goal for their child to sleep in their
own bed were accomplished after the onset of treatment, and these outcomes were
maintained across all children. Each of these outcomes offers compelling evidence for
experimental control in a single-subject, non-concurrent multiple baseline design and
meaningful implication for the effectiveness of BFRC as a parent-implemented homebased intervention.
This is the first study to demonstrate BFRC as an effective intervention for the
elimination of undesired co-sleeping in children with ASD. Previously, Ashbaugh and
Peck (1998) found that BFRC eliminated undesired co-sleeping with a typically
developing child, whereas others (Piazza and Fisher, 1991b; Piazza, Fisher, and Moser,
1991) noted reductions in undesired co-sleeping among children diagnosed with nonASD neurodevelopmental disorders. Previous BFRC studies in children with ASD
primarily focused on changes in disruptive sleep-related behaviors, sleep latency, night
awakenings, or sleep duration (DeLeon, Fisher, & Marhefka, 2004; Moon, Corkum, &
Smith, 2010; Piazza, Fisher, & Sherer, 1997). The current study evaluated additional
parent-determined sleep goals (i.e., reduce night awakenings and sleep onset, set bedtime,
and obtain developmentally appropriate amount of sleep) as primary sleep problems and
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sleep problems not identified as parent goals (i.e., BR, DBC, DSO, WASO, TIB, TST,
SE) as secondary sleep problems. Nevertheless, these outcomes provide further evidence
for a positive change following BFRC.
Above and beyond the complete elimination of undesired co-sleeping, Holly also
demonstrated meaningful improvements in sleeping in her own bed, falling asleep
independently, and bedtime resistance. At the onset of treatment, Holly’s parents no
longer had to remain next to her to get her to fall asleep or to sleep in her own bed
throughout the night. Moreover, Holly no longer engaged in disruptive behaviors during
her bedtime routine or after she was placed in her bed for the night. Time spent engaging
in bedtime resistance dramatically improved after the onset of BFRC. These changes
were clinically important to Holly’s parents because a substantial portion of their
evenings were no longer occupied by conflict over sleep. Occasionally, she continued to
come out of her bedroom after being put in bed for the night; however, frequencies of
these minor disturbances remained below baseline levels at follow-up.
Depending on the measurement method, Holly’s overall total sleep time
decreased (sleep diary) or increased (actigraphy) from baseline to the end of follow-up.
Unlike the other two children in this study, Holly did not experience difficulties with
night awakenings prior to treatment. Nonetheless, both the number and the duration of
night awakenings varied greatly during treatment and eventually returned to near baseline
levels. This putative suppression of night awakenings during baseline may stem from her
sleeping through the night in her parents’ bed with at least one parent in the room.
Therefore, Holly’s night awakenings began after access to co-sleeping with a parent and
dependent sleep onset were eliminated. It is worth noting that Holly experienced a change
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in routine the last night of follow-up, which might have contributed to sleep problems
experienced that night.
In addition to the elimination of undesired co-sleeping, Bill also experienced
noteworthy improvements in sleep latencies, bedtime resistance, and the number of night
awakenings and started sleeping in his own bed and falling asleep independently. After
the onset of BFRC, Bill no longer sought parental presence to initiate or reinitiate sleep
and he was able to sleep through the night in his own bed independently. He also engaged
in fewer disruptive behaviors during his bedtime routine that continued to improve
throughout treatment and follow-up. By the end of follow-up, Bill was able to
consistently achieve sleep onset within 15 minutes of bedtime. This outcome was
clinically significant because prior to intervention Bill often took one to two hours a night
to fall asleep, which may have inadvertently disrupted his parents’ sleep.
According to both subjective and objective measures, Bill’s overall total sleep
time increased from baseline to the end of follow-up. Night awakenings also
progressively improved throughout treatment, however, Bill might have achieved greater
improvement had it not been for a change in schedule and lack of daytime activity the
second to last day of treatment. That same night, he experienced more frequent and
longer lasting disruptive behaviors than he had the previous ten nights of treatment and
spent the least amount of time sleeping out of any night during the entire study. Bill also
took longer to fall asleep than he did the two nights before and had more night
awakenings than he did the previous four nights. Nonetheless, his night awakenings were
completely eliminated during follow-up.
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Keith also demonstrated considerable improvements over and above a significant
reduction in undesired co-sleeping, specifically in night awakenings, sticking to a set
bedtime, sleeping in his own bed, falling asleep independently, and bedtime resistance.
After the onset of BFRC, Keith experienced fewer night awakenings, which completely
disappeared toward the end of treatment and remained absent throughout follow-up. As
opposed to Holly’s data, Keith’s overall total sleep time from baseline to the end of
follow-up increased, based on sleep diary data, or decreased, based on actigraphy data.
Furthermore, Keith no longer required a parent in the room or in bed with him to fall
asleep at bedtime or after night awakenings. Keith also engaged less often in bedtime
refusal, following an expected extinction burst the first night of BFRC, when he was no
longer permitted to sleep in his parents’ bed or with a parent in the room.
Overall, the occurrence of Keith’s sleep-related disruptive behaviors gradually
declined throughout treatment and remained rare at follow-up, with the exception of an
unexplained uptick. A steady upward trend in the length of time Keith engaged in
bedtime resistance began the third night of treatment, reaching its peak on the sixth night.
The following night marked the descent to near baseline levels. Unfortunately, no
information was provided that could reasonably account for this change in trend. As for
sleep latencies, Keith’s data showed a sharp increase on the first night of treatment,
followed by a progressive decline that was maintained during follow-up. This pattern
likely indicates that for this child, the onset of treatment temporarily altered his sleep
latency, and he was able to eventually adjust to his original set point of sleep onset within
15 minutes of being placed in bed. Furthermore, this improvement was not clinically
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meaningful as he was already achieving sleep within an acceptable range of latency
(average within 10 minutes of being placed in bed) before treatment.
In all BFRC studies with children on the autism spectrum, researchers determined
treatment onset and primary sleep outcomes, with the exception of Piazza and colleagues
(1997), who used sleep norms in conjunction with parent preferences to establish
children’s sleep and wake times. In the current study, two children (Holly and Keith) had
parent-determined goals for sleep duration based on sleep norms (Iglowstein, et al.,
2003). At the time of our study, the most current and complete sleep duration norms
available were based on the combined results of two longitudinal studies conducted with
Swiss children (Iglowstein, et al., 2003). Based on these norms and lofty parent goals, it
is not surprising that neither Holly nor Keith attained total sleep time goals after the onset
of treatment. This may be partly because children with ASD tend to sleep less compared
with typically developing peers (Hodge, Carollo, Lewin, Hoffman, & Sweeney, 2014).
Compared with other studies with children on the autism spectrum (Durand & Mindell,
1999; Moon, Corkum, & Smith, 2010; Schreck & Mulick, 2000), Holly’s and Keith’s
sleep durations appeared to fall within the normal range for their age. Therefore, both
parent dyads might have overestimated their child’s need for sleep.
As previously described, two children (Bill and Keith), whose parents had a goal
of reducing the number of night awakenings, experienced an overall improvement during
treatment and total elimination during follow-up. These results are consistent with the
findings of two studies (Piazza, Fisher, and Sherer,1997; DeLeon, Fisher, and Marhefka,
2004) in that night awakenings were nearly eliminated following BFRC in children with
ASD. Consistent with findings by Moon, Corkum, and Smith (2010), mean sleep onset
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latency as measured by both actigraphy and sleep diary revealed an overall decease from
baseline following BFRC for two children (Bill and Holly) with ASD. BFRC was also
effective in reducing the duration and frequency of disruptive sleep-related behaviors for
all three children. Moreover, BFRC produced a clinically significant improvement in
CSHQ-A total scores for three children with severe ASD.
Prior to treatment, parent-reported total sleep disturbance scores indicated that
their children experienced dyssomnia-type sleep problems in the clinical range. Two
children (Holly and Bill) greatly improved, their problems moving from the clinical range
to the non-clinical range by the end of follow-up. However, one child (Keith), who
experienced the greatest improvement with the largest reduction in scores out of all three
children, was only one point above the clinical cut-off score by the end of the follow-up.
These parent-reported scores on each subscale are consistent with night-by-night data
from sleep and behavior diaries, indicating an overall positive change with less bedtime
resistance for all three children, fewer night awakenings and longer sleep duration for Bill
and Keith, and less sleep onset delays for Bill. Actigraphy data further support these
positive changes in sleep onset delays and sleep duration for Bill. These outcomes offer
strong support for BFRC successfully treating a wide variety of multiple co-occurring
disruptive sleep and related problem behaviors in children on the autism spectrum.
The total amount of time spent sleeping in a 24-hour period was greater when
recorded in sleep diaries vs. by actigraphy across all three children. Furthermore, the
average amount of time spent in bed as recorded by both sleep diaries and actigraphy
significantly reduced from baseline to follow-up for all three children. This reduction in
time spent in bed likely produced the observed improvements in sleep efficiency.
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According to sleep diary data, each child was already achieving sleep efficiency within
the low-end of normal (85%) to high (97%) range prior to treatment. However,
actigraphy data produced lower sleep efficiencies, compared with sleep diary data, for
each child.
In contrast to findings by Moon, Corkum, and Smith (2010), there was a pattern
of change in mean sleep efficiency as measured by actigraphy for two children. Holly’s
and Bill’s sleep efficiency increased after treatment, and mild improvements were
maintained at follow-up, whereas Keith’s mean sleep efficiency remained at 89%
throughout the study. For all three children, the amount of time spent awake after sleep
onset recorded by actigraphy was greater than time recorded in sleep diaries, which was
nearly zero. Similarly to the improvements of night awakenings recorded in sleep diaries,
two of the three children spent no time awake after sleep onset by follow-up, whereas the
third child might have continued the pattern of zero time awake after initially falling
asleep had she not experienced a change in routine on the final night of follow-up.
In the present study, all parent dyads reported high levels of satisfaction with
BFRC and its results and were willing to strongly recommend this treatment to others.
This outcome is similar to high parent satisfaction with treatment reported in the one
other BFRC study that used parents as change agents in the home setting with children
with ASD (Moon, Corkum, & Smith, 2010). In our study, parents reported the use of
structured guidelines and the elimination of undesired co-sleeping as being the most
helpful components. In sum, these parent opinions suggest that benefits outweighed the
challenges and support the social importance of BFRC as an effective parentimplemented treatment. Only one parent satisfaction item was rated negatively. This
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discrepancy might be explained by a change in response item value and topographical
similarity between Very unconfident and Very confident rather than a true endorsement of
low confidence in their ability to manage their child’s current problem behaviors. For
example, these parents wrote, “The treatment was awesome. It gave us the tools we
needed.” Therefore, this score should be interpreted with caution. As such, this minor
inconsistency does not diminish the overall high level of parent satisfaction across all
three families and the social validity of BFRC as a feasible parent-implemented in-home
treatment for children with ASD and multiple co-occurring sleep problems.
We explored the impact of changes in sleep problems on marital satisfaction.
Holly’s parents each experienced some minor improvement in marital satisfaction at the
end of treatment. This slight improvement does not provide sufficient evidence to support
the impact of BFRC on marital satisfaction; however, previous findings (Fisman, Wolf,
& Noh, 1989; Mihaila & Hartley, 2016) suggest various explanations for this change. For
instance, an increase in martial satisfaction might indicate that Holly’s parents’ sleep also
improved, thus increasing each parent’s positive affect (Mihaila & Hartley, 2016).
Likewise, removing Holly from her parents’ bed might have had a positive impact on the
quality of their marriage by allowing for more time alone with each other (Fisman, Wolf,
& Noh, 1989). Bill’s and Keith’s parents consistently endorsed being extremely satisfied
with their marriage, his or her spouse, and his or her relationship with their spouse.
Although a ceiling effect left little room for improvements in martial relations, these
results do indicate that BFRC did not produce a decline in couple’s marital satisfaction.
Piazza, Fisher, and Sherer (1997), DeLeon, Fisher, and Marhefka (2004), and
Moon, Corkum, and Smith (2010) provided foundational evidence for BFRC as a

65

BEDTIME FADING WITH RESPONSE COST
promising intervention for sleep disturbances experienced by children with ASD. Our
study expands upon this research in a number of ways. First, the current study addresses
the lack of agency parents have been given when children participate in treatment-related
research. Parents, not researchers, determined the treatment goals and the primary
outcome variables. The current method enhances the social validity of BFRC and the
social significance of the positive findings. Second, the current study obtained actigraphy
data as an objective measure of the sleep-related outcome variables.
Third, a non-concurrent multiple baseline across subjects design was employed in
place of a more rigorous design due to its feasibility in applied settings and in an attempt
to avoid potential temporal delays in participant enrollment (Watson & Workman, 1981).
Nonetheless, we met experimental design requirements (Harvey, May, & Kennedy, 2004)
by staggering baseline durations across the three participants and planning for the
implementation of BFRC. For example, BFRC was introduced after baseline data on the
frequency of the primary target behavior (i.e., undesired co-sleeping) were determined
stable (4 consecutive days for Holly and 6 consecutive days for Bill) or after 14
consecutive days of data collection, as done for Keith. The maximum of 14 consecutive
days represents a potential methodological weakness; however, this two-week limit was
chosen based on clinical considerations for the participants and their families.
Experimental control was demonstrated by a functional relationship between the
implementation of BFRC and observable changes in the frequency of undesired cosleeping for each child.
In addition, results from a small sample might not generalize to a wider
population. We did not evaluate the extent to which each parent dyad worked together.
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We did encourage both parents to implement treatment and designated one parent
responsible for data recording; therefore, it is unclear if a single parent could effectively
implement treatment and achieve similar results. In addition, this study focused on
preschool and school-aged children, who largely depend on parents to structure their
sleep routine and sleep environment. It would be beneficial to determine if parents of
adolescents with ASD can effectively implement BFRC with comparable outcomes.
Nevertheless, BFRC was effective for three young children with severe autism and
multiple co-occurring sleep problems, who were living in a two-parent household. A
randomized controlled trial would strengthen the external validity of these findings and
help to determine effective levels of parental participation.
Lastly, we did not include an objective measure such as video recording to
confirm procedural integrity or collect IOA to document the reliability of data collection
procedures. Based on clinical considerations (Burke, Kuhn, & Peterson, 2004; Durand &
Mindell, 1999; Vollmer & Sloman, 2008), we selected telephone checks, a less intrusive
method, to ensure ongoing and timely data collection and to obtain data on treatment
integrity.
Behavior analysts have a great appreciation for precise terminology that conveys
information effectively. Response cost is best described as a punishment procedure in the
form of a penalty, which may not be the most accurate label for the response extinction
components of the BFRC sleep intervention. Although terminological refinement may be
warranted, perhaps the more salient endeavor lies in conceptualizing the effectiveness of
BFRC using behavioral processes and concepts. Respondent conditioning, operant
conditioning, and the value altering effects of motivating operations all contribute to
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understanding the socially significant phenomenon of sleep. As such, the process of
respondent and operant conditioning and motivating operations may all contribute to the
effectiveness of the BFRC procedure.
Respondent conditioning may contribute through a stimulus-stimulus pairing
process, in which an unconditioned stimulus (UCS) becomes a conditioned stimulus (CS)
that elicits the conditioned response (CR). From a respondent conditioning standpoint,
the UCS is somnolence (i.e., physiological state of sleepiness), which is often associated
with delaying bedtime and limiting access to the unconditioned response (UCR) of sleep.
Delaying the initial bedtime component of the BFRC procedure increases the likelihood
of the child achieving sleep onset within 15 minutes of being placed in bed. The behavior
of lying down in bed may have become a CS that functions as a signal for initiating sleep.
If the child falls asleep soon after being placed in bed, the CS effectively elicited the CR
of sleep.
Operant conditioning, that is, the basic process of learning that occurs when a
stimulus changes immediately following a response, resulting in changes in the behavior
when under similar conditions in the future, may also contribute to the effectiveness of
the BFRC procedure. Prior to treatment, the child had access to preferred activities,
parental attention, and the opportunity to fall asleep whenever he or she became sleepy,
whereas during treatment the parent controls such accessibility and opportunities. In the
BFRC treatment, the child has 15 minutes to fall asleep once being placed in bed,
otherwise he or she is removed from bed and does not have another opportunity to sleep
for 30 minutes. The stimulus change of being removed from bed occurs immediately
following the child’s response of being awake in bed. Although the child has access to
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preferred activities and parental attention, access to sleep is restricted until the next
scheduled bedtime. As the child’s sleepiness increases, being removed from bed becomes
an unpleasant event. The child learns to avoid being removed from bed by engaging in
sleep-compatible behaviors or achieving rapid sleep onset.
Motivating Operation (MO) is a behavioral concept used to explain variations in
the strength of value-altering and behavior-altering effects (Michael, 1982; Michael,
2000). Sleep deprivation is one of the primary MOs identified in humans. It is the current
strength of sleepiness that can alter the reinforcing value of consequences and change the
probability of behaviors. That is, extreme sleepiness can increase the effectiveness of
sleep as reinforcement and increase the current frequency of sleep-compatible behavior
(e.g., lying down in bed) that has been reinforced by sleep. As such, MOs alter the
effectiveness of both respondent and operant conditioning. Delaying the child’s bedtime
and restricting access to sleep alters the reinforcing value of sleep and changes the
probability of achieving rapid sleep onset and engaging in sleep-compatible behaviors.
When the duration of time children spend awake in bed is reduced, the experience of
sleepiness and sleep onset comes under stimulus control of the bedtime routine, the bed,
and other aspects of the bedroom environment. Therefore, the BFRC procedure makes
the most out of naturally occurring sleep processes (i.e., motivating operations) while
teaching more appropriate sleep associations (i.e., stimulus control).
In summary, this investigation expands research on BFRC as a home-based,
parent-delivered intervention for undesired co-sleeping with co-occurring sleep problems
experienced by children with severe ASD. This investigation sets the stage for
empowering parents to function as the agents of change by utilizing their own treatment
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goals and making them responsible for implementing BFRC. Moreover, this study
provides evidence that elevates BFRC toward to a new classification tier as a well
established empirically supported treatment (Chambless & Hollon, 1998). In conclusion,
the results of this study provide evidence for parent implementation of BFRC as a
behavioral treatment option for children with ASD and multiple sleep problems. Future
research should center on generalizing these favorable outcomes.
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Table 1
Participant Information
Holly
Bill
Keith
Age in years
8.5
7
4.5
Gender
Female
Male
Male
ADOS-2
Overall total
13
24
24
Comparison score
6
10
10
Classification
Autism
Autism
Autism
CARS-2
Raw score
31*
44
39
T-score; percentile
51; 54th%
57; 76th%
51; 54th%
Severity group
Severe
Severe
Severe
Sleep problems meeting selection criteria


Requires parent in room to fall asleep


Refusal to sleep in own bed



Undesired co-sleeping

Bedtime resistance


Sleep onset latency


Night awakenings
Note: An ADOS-2 Comparison score of 6 indicates a moderate level of autism spectrum,
while a score of 10 indicates a high level of autism spectrum. * Scores for this participant
were taken from the CARS-2 High Functioning (HF) version, as opposed to the Standard
(ST) version of the measure.
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Table 2
Dependent Variables on Sleep Diary & Sleep Related Behavior Diary
Dependent Sleep Variables
Frequency of Night-Awakenings
(FNA)
Waking-up After Sleep Onset
(WASO)

Sleep Onset Latency (SOL)

Total Sleep Time (TST)

Time in Bed (TIB)

Dependent Sleep Onset (DSO)

Independent Sleep Onset (ISO)

Dependent Sleep Related Behavior
Variables
Undesired Co-Sleeping (UC-S)

Sleeping in a Non-Designated Area

Location of Non-Designated Sleep

Definitions
Total number of times child awoke during the
night and got out of bed; Marked by time with
an up arrow, not including final rising
Total minutes the child is awake after initially
falling asleep; Non-shaded in boxes of time
(small box = 15 min.; large box = 1 hour) after
initial sleep onset, until time of final rising
The time between initially being placed in bed
awake, marked by time with a down arrow, and
the time of sleep onset each night, marked by
shaded in boxes
Total duration of nighttime and daytime sleep
acquired within 24-hours; Shaded in boxes for
when the child is asleep (small box = 15 min.;
large box = 1 hour)
Amount of time the child was physically in bed
during within 24-hours; Time child gets into bed
marked by a down arrow until final rising
The achievement of sleep with the required
assistance of a parent; Marked by the letter D
next to a down arrow
The achievement of sleep without the assistance
of a parent; Marked by the letter I next to a
down arrow
Definitions
Unwanted co-sleeping with a parent or sibling in
any room during a 24 hour period; Frequency
and duration of undesired co-sleeping with
parent(s) or siblings by child
Frequency of child sleeping in a location other
than the child’s bed (e.g., couch, car, floor, etc.)
during a 24 hour period
Location of undesired co-sleeping with child
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Table 3
Session Timeline
Weekly
Sessions
Session 1:
Session 2:
Session 3:
Session 4:
Session 5:
Session 6:
Session 7:
Session 8:

Activities
Intake interview, CARS-2, ADOS-2, KMSS, and consent
Identify parent sleep goals, teach data collection, give actigraphy, and
start baseline data collection
Review week one baseline data and determine treatment or cont.
baseline
Review week two baseline data or week one treatment data. Cont. or
discontinue treatment
Review week one or week two of treatment data. Cont. or discontinue
treatment
Review week two of treatment data or begin follow-up data collection
(4-weeks post treatment)
Begin (4-weeks post treatment) or end (7 days) follow-up data
collection.
End follow-up data collection

88

Goals

100%
75%
100%
64%a
18%b
82%c

0%
50%a
50%b
25%c

Phases
EOT

0%
0%

BSL

100%
100%a
50%b
100%c

100%
100%

FU

57%a
57%a
71%a
36%b
21%b
43%b
50%c
64%c
29%c
2. Fall asleep on own (in own bed); (% of nights per phase)
0%
100%
100%
3. Bedtime between 7:00-7:30 p.m.(% of nights per phase)
1%
43%
86%
4. Sleep through the night in own bed (return to sleep during the night by himself); (% of nights per phase)
0%
93%
75%
Note: BSL = Baseline; EOT = End of treatment; FU = Follow-up; SOL = Sleep onset latency; Developmental sleep norms according to a
Hirshkowitz, et al., 2015; b Iglowstein, Jenni, Molinari, & Largo, 2003; c Hodge, Carollo, Lewin, Hoffman, & Sweeney, 2013.

Keith’s parent-stated goal and (parent-therapist collaborated goal); (GAS %)
1. Get enough sleep (get developmentally appropriate amount of sleep each night); (% of nights per phase)

Bill’s parent-stated goal and (parent-therapist collaborated goal); (GAS %)
1. Sleep through the night in own bed; (% of nights per phase)
2. Go to sleep sooner (reduce SOL each night); (% of minutes per phase)
Holly’s parent-stated goals and (parent-therapist collaborated edit to goals); (GAS %)
1. Sleep in own bed (every night); (% of nights per phase)
2. Get required amount of sleep for age (every night); (% of nights per phase)
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Table 4

Goal Achievement Scales (GAS)
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!

667.25;
(53.74)

399.25;
(68.06)
60.03%;
(10.1)
192; (69.2)

43.5; (39.72)

BSL

15; (0)

BR (mean min.; SD)

1
3
5
6
3
40

475.25;
(48.32)
74.75%;
(11.09)
132.5;
(102.86)
642; (70.24)

31.5; (16.98)

FU

0; None

None

0; (0)

0.36; (0.23) 0.25; 0.23)

0; None

None

0; (0)

17.72; 26.25; (22.5)
(22.06)
550.90;
577.5;
(48.41)
(25.98)
87.85%
94%
28.63; 11.25; (22.5)
(32.48)
625.90; 615; (36.74)
(11.79)
0.72; (0.94) 0.5; (1)
0; (0)
0; (0)

N/A
N/A
N/A
N/A
N/A
N/A

13.81;
(17.89)
491.27;
(75.69)
81.08%;
(10.73)
91.27;
(74.10)
605.18;
(40.07)

Holly
EOT

0.16; (0.40);
N/A
12.41; (8.16)

Parents’ bed

230; (56.65)

1.16; (0.41)
1.16; (0.40)

595; (22.58)

502.5;
(36.43)
84.6%
35; (7.74)

57.5; (45.9)

3
5
7
9
3
48

414.5;
(56.96)
68.23%;
(10.15)
104.83;
(70.33)
608.5; (9.81)

73.5; (24.99)

BSL

FU

0: None

None

0; (0)

25.71;
(36.47)
445.71;
(65.09)
85.82%
40.71;
(52.10)
520.71;
(40.94)
1; (1.11)
0; (0)

1
5
6
6
4
43

507.85;
(42.76)

0; None

None

0; (0)

0; (0)
0; (0)

547.5; (15)

97%
0; (0)

532.5; (15)

11.25; (7.5)

1
3
4
6
3
36

548.5;
(15.96)

23.71;
31; (INC)
(32.91)
401.64;
463.75;
(94.55)
(INC)
79.68%;
84.49%;
(18.79)
(INC)
49.85; (27) 49.75; (INC)

Bill
EOT

1
3
5
6
3
42

89.02%;
(6.13)
57.28;
(39.90)
567.14;
(60.16)

502; (27.77)

5.57; (4.46)

FU

56.78;
1.07; (4)
8.57; (17)
(71.77)
Parents’ bed, Parents’ bed Parents’ bed
child’s bed
0.13; (0.35); 0.06; (0.25);
0; None
car, couch
car
1.32; (2.09) 6.32; (7.94) 0.07; (0.18)

612.85;
(59.64)
0; (0)
0; (0)

33.21;
4.28; (7.31)
(38.21)
578.57;
608.57;
(60.20)
(57.35)
91.5%
99.32%
6.42; (12.77)
0; (0)

1
3
4
7
3
46

INC

INC

INC

INC

INC

Keith
EOT

598.92;
(60.99)
94%
10.07;
(19.92)
637.5;
624.64;
(52.87)
(51.16)
0.64; (0.74) 0.28; (0.46)
1.71; (0.91)
0; (0)

9.64; (13.93)

1
6
7
12
4
60

50.78;
(51.13)
598.12;
(120.35)

524.92;
(91.64)
88.57; (7.83)

13; (10.14)

BSL

55.10;
4; (0)
(70.24)
DBC (mean scores; SD)
1.25; (0.5) 1.18; (0.98) 0.5; (0.57)
5.33; (3.98) 5.71; (4.66)
2; (0)
1.07; (1.07) 2.21; (2.0) 0.14; (0.37)
Note: BSL = Baseline; EOT = End of treatment; FU = Follow-up; SOL = Sleep onset latency; TST = Total sleep time; SE = Sleep efficiency; WASO = Waking-up after
sleep onset; TIB = Time in bed; CSHQ-A = Children Sleep Habits Questionnaire Abbreviated; FNA = Frequency of night awakenings; DSO = Dependent sleep onset;
UC-S = Undesired co-sleeping; N-DS = Non-designated sleep; BR = bedtime resistance; DBC = Disruptive behavior composite; N/A = Not available; INC = Incomplete
data due to software malfunction.

0; None

652.5;
(46.63)
Parents’ bed

671.25;
(49.56)
0; (0)
1; (0)

652.5;
(46.63)
97.18%
0; (0)

N-DS (mean freq.; SD; location)

UC-S (location)

FNA (mean freq.; SD)
DSO (mean freq.; SD)
Behavior diary
UC-S (mean min.; SD)

TIB (mean min.; SD)

SE (%)
WASO (mean min.; SD)

TST (mean min.; SD)

CSHQ-A Subscale raw scores
Sleep onset delay (range: 1-3)
1
Sleep duration (range: 3-9)
3
Night wakings (range: 3-9)
5
Bedtime resistance (range: 6-18)
14
Sleep disordered breathing (range: 3-21)
4
CSHQ-A Total scores
56
Sleep diary
SOL (mean min.; SD)
18.75; (7.5)

TIB (mean min.; SD)

WASO (mean min.; SD)

SE (%; SD)

TST (mean min.; SD)

Actigraphy
SOL (mean min.; SD)

Dependent Variables
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Table 5

Sleep Variables (Actigraphy, CSHQ-A, Sleep and Behavior Diaries)

!

Holly’s Parents
BSL EOT
FU

Bill’s Parents
BSL EOT
FU

Keith’s Parents
BSL EOT
FU

!

KMSS total score
Maternal score
17
17
18
21
21
21
21
21
21
(range: 3-21)
Paternal score
17
17
18
21
21
21
21
21
21
(range: 3-21)
Note: BSL = Baseline; EOT = End of treatment; FU = Follow-up; KMSS = Kansas Marital
Satisfaction Scale.

Scores
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Table 6

Marital Impact Variable, Kansas Marital Satisfaction Scale (KMSS)

Questions

Parent Scores
Holly Bill Keith
7
7
7
7
7
7
4
5
4
7
7
7
6
5
6

1. The major problem(s) that originally prompted me to begin treatment for my child is (are) at this point
2. My child’s problems that have been treated during the study are at this point
3. My child’s problems that have not been treated during the study are
4. My feelings at this point about my child’s progress are that I am
5. To what degree has the treatment program helped with other general personal or family problems not directly
related to your child?
6. At this point, my expectation for a satisfactory outcome of the treatment is
7
7
6
7. I feel the approach to treating my child’s sleep problems in the home by using this type of parent implemented
7
7
7
treatment program is
8. Would you recommend the treatment program to a friend or relative?
7
7
7
9. How confident are you in managing current sleep problems in the home on your own?
7
7
1*
10. How confident are you in your ability to manage future sleep problems in the home using what you learned from
7
7
7
this study?
11. My overall feeling about the treatment program for my child and family is
7
7
7
Note: 1Adapted from Helping the Noncompliant Child (2nd ed.) by Robert J. McMahon and Rex L. Forehand. Copyright 2003 by The
Guilford Press. Permission to photocopy this form is granted to purchasers of this book for personal use only. Research questionnaire was
rated using a 7-point Likert scale (1 = Very dissatisfied; 7 = Very Satisfied) and response options varied by question (example: questions 1, 2,
and 3 offer 1 = Considerably worse; 7 = Greatly improved); *Questions 8 and 9 are worded and scored in reverse order and may be
responsible for this score inconsistency.

!
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Table 7

Parent’s Consumer Satisfaction Questionnaire1 (PCSQ)
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Frequency of Undesired Co-sleeping
4

Baseline

Treatment

Follow-up

Holly
3
M=1

M=0

M=0

2

1

0
1

6

11

16

21

26

31

Frequency

4

Bill

3
M=1

2

M=0

M=0

7

1

0
1

6

11

16

21

26

31

4
M=2

M=.07

M=.29

Keith

3

2

1

0
1

6

11

16

21

26

31

Nights
Figure 1. Frequency of undesired co-sleeping per night with parents across children.

!
!

!
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Duration of Undesired Co-sleeping
800 Baseline
700

Treatment

Follow-up

Holly

600
500

M=653

M=0

M=0

400
300
200
100
0
1

6

11

16

21

26

31

400

Minutes

350

Bill

300
250
200
150

M=0

M=230

M=0

100
50
0
1

6

11

16

21

26

31

400
350

Keith

300
250

M=57

200

M=1

M=9

150
100
50
0
1

6

11

16

21

26

Nights
Figure 2. Duration of undesired co-sleeping with parents across children.

!
!

31

!
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Duration of Bedtime Resistance
20

Baseline

Treatment

Follow-up

Holly
15
M=15

M=.36

M=.25

10

5

Change in routine

0
1

6

11

16

21

26

Change in
routine

200

Bill

150

Minutes per night

31

M=12.4

100

M=55.1

M=4

50

0
1

6

11

16

21

26

31

25

Keith

20
M=1.3

M=6.3

15

M=.07

Change
in
routine

10
5
0
1

6

11

16

21

26

31

Nights
! children.
Figure 3. Duration of bedtime resistance across
!

!
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Disruptive Behavior Composite
4

Baseline

Treatment

Follow-up

Holly
3

M=1.3

M=1.2

M=.05

2

Change in routine

1

0
1

6

11

16

20

Composite Scores

16

21

26

Change
in
routine

M=5.3

M=5.7

31

Bill

M=2

12
8
4
0
1

6

11

16

21

26

31

8

Keith
6
M=2.2

M=1.1

4

M=.14

Change
in
routine

2

0
1

6

11

16

21

Nights
Figure 4. Disruptive behavior composite scores
! across children.
!

26

31

!
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Frequency of Night Awakenings
5

Baseline

Treatment

Follow-up

Holly

4

M=.73

M=0

M=.50

3

Change in routine

2
1
0
1

6

11

16

21

26

31

5

Bill

4
M=1.2

M=1

Frequency

3

Change in
routine

M=0

2
1
0
1

6

11

16

21

26

31

5

Keith

4
M=.64

3

M=.36

M=0

Change in
routine

2
1
0
1

6

11

16

21

26

31

!

!

Nights
Figure 5. Frequency of night awakenings across children.

!
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Frequency of Dependent Sleep Onset
4

Treatment

Baseline

Follow-up
Holly

3
M=1

M=0

2

1

0
1

6

11

16

21

26

31

4

Bill

3
M=1.2

M=0

M=0

Frequency

2

1

0
1

6

11

16

21

26

31

4
M=1.7

M=0

M=0

3

Keith

2

1

0
1

6

11

16

21

26

31

Nights
Figure 6. Frequency of dependent sleep onset (DSO) per night across children.
!

!

!
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Appendix A
Sample sleep diary data sheet.
Instructions: Please complete the sleep diary during the evening and morning each day
within the same 24-hour period. The same person should complete all diaries. Record the
date and the following information:
1. Mark the time your child gets into bed with a down arrow “”;
2. Mark the time your child gets out of bed with an up arrow “”;
3. Shade in boxes when your child is asleep (small box = 15 minutes; large box =
1 hour); 4. Mark a “W” next to the arrow if your child was awaken by a parent or
alarm; mark an “S” if your child awakened by his/herself; and
5. Mark a “D” if your child falls asleep dependently (with parental presence) or an
“I” if your child falls asleep independently (without parental presence).
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Appendix B
Sample sleep related behavior diary data sheet.
Instructions: Please complete the sleep related behavior diary during the evening and
morning each day within the same 24-hour period. The same person should complete all
diaries. Mark a tally in the corresponding box and record the duration of each instance the
child engages in a disruptive behavior during the bedtime routine and once placed in bed,
undesired co-sleeping, and sleep in a non-designated area. Record the date, the time the
child gets ready for bed, the time and reason for removing the actigraphy, and the
locations of undesired co-sleeping and non-designated sleep. Please use the following
definitions:
1. Disruptive behaviors are defined as one or more verbal protests and/or
physical protests a night when instructed by a parent to go to bed or go to
sleep;
2. Sleeping in a non-designated area is defined as one or more occurrences of
sleeping in a location other than the child’s bed during a 24 hour period; and
3. Co-sleeping is defined as unwanted sleeping with a parent or sibling in any
room during a 24-hour period.
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Appendix C
Sample integrity-monitoring data sheet.
Instructions: Record parent responses as reported in the corresponding boxes. Record
“Y” for “yes”, “N” for “no”, or “N/A” for not applicable to the context.
Tri-weekly
phone-check
Date and time of call
(e.g., 8/14/13; 8:00am)
Indicate the caller’s
initials
Parent answer the phone
(Y, N, or N/A)
Return call by 5:30 p.m.
(Y, N, or N/A)
Bedtime Fading
(BF)
Was BF implemented?
(Y, N, or N/A)
Time placed child in bed
last night?
Time checked to see if
child was sleeping?
How did you determine
if your child was
sleeping?
What did you do after
your child was or was
not sleeping?
Response cost
(RC)
Was RC implemented?
(Y, N, or N/A)
Time child was taken out
of bed and bedroom?
What did your child do
during that time?
Time returned child to
bed last night?
Time checked to see if
child was sleeping?
How did you determine
if your child was
sleeping?
What did you do after

1

2

3

4

5

6

7

1

2

3

4

5

6

7

1

2

3

4

5

6

7

BEDTIME FADING WITH RESPONSE COST
your child was or was
not sleeping?
How many times was RC
repeated?
What time did your child
finally fall asleep?
Call #
Notes:
Barriers:
Solutions:

Call #
Notes:
Barriers:
Solutions:

Call #
Notes:
Barriers:
Solutions:

Call #
Notes:
Barriers:
Solutions:

Call #
Notes:
Barriers:
Solutions:
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Appendix D
Sample vignettes of sleep patterns and related behaviors.
Please complete the sleep diary and sleep related behavior diary using the information
presented below. If you have any questions, please do not hesitate to ask the investigator
before leaving your session.

Vignette 1.
On Saturday 6/22/13, James went to bed by himself at 9:00 p.m. and fell asleep at
9:45 p.m., alone. He awoke on his own at 12:30 a.m. and was put back to bed at
1:45 a.m. by his mother. James fell asleep at 2:00 a.m. by himself and slept till his
father woke him at 7:30 a.m..

Vignette 2:
On Sunday 6/30/13, Chelsea was put to bed by her father at 8:30 p.m. and fell
asleep at 10 p.m. with her father in the room. Chelsea awoke at 2:30 a.m. and
went to sleep by herself around 3:30 a.m.. She woke up at 5:00 a.m. on her own,
but did not leave her bed until 6:00 a.m.. Chelsea fell asleep in the car on the way
to daycare from 7:30 a.m. till 8:00 a.m. and woke-up independently. On the way
home from daycare she slept in the car from 5:30 p.m. till her father woke her up
at around 6:35 p.m..
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10:15pm. If your child did not fall asleep within 15 minutes of the initial bedtime, push back the bedtime to 10:45pm.

your child’s initial bedtime was 10:30pm and he/she fell asleep within 15 minutes of being placed in bed, fade the bedtime to

(i) Adjust the bedtime for the following night according to your child’s previous time of sleep onset by 15 minutes. For example, if

(e) Bedtime fading:

(d) Address night time awakenings by returning your child to his or her bed with minimal parental attention and interaction.

(c) Repeat the procedure if your child does not fall asleep within 15 minutes of being returned to bed.

(ii) At the end of 30 minutes, return your child to his or her bed.

such as playing with toys or watching T.V.

(i) Remove your child from the bed and bedroom and allow him or her to partake in activities not related to sleep for 30 minutes,

(b) Response cost:

(iii) If you determine your child is awake (i.e. he/she responded to your whisper), implement response cost.

there are no observable motor or verbal responses (i.e. opening eyes, talking, etc.) it is safe to assume your child is asleep.

(ii) After 15 minutes, check to see if your child is awake by standing within one foot of the bed and whispering his or her name. If

(i) Follow your regular bedtime routine and place your child in his or her bed at the initial adjusted bedtime.

(a) Bedtime procedures:

BEDTIME FADING WITH RESPONSE COST
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Appendix E
Sample bedtime fading with response cost treatment protocol.

